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 Osteoporosis is a skeletal disorder associated with decreased bone mass and 
compromised bone strength, often leading to increased risk of fragility fractures and 
delayed fracture healing response. The most common form of osteoporosis is the 
postmenopausal osteoporosis which occurs predominantly in elderly females due to 
estrogen deficiency. Estrogen deficiency triggers an increase in bone remodeling, which 
is characterized by increased osteoclastic activity (bone resorption), and increased but 
relatively deficit osteoblastic activity (bone formation). This causes rapid loss of bone 
mass and micro-architecture, resulting in osteoporosis. The effects of estrogen on bone 
forming osteoblasts cells had been extensively studied on the basis of cellular and 
molecular response. However, the mechanistic perspective of the effects of estrogen on 
osteoblasts has not been documented before. Being mechanosensory cells themselves, the 
mechanical property of osteoblasts could bear implications for their physiological 
functions.  
This study attempted to document the direct in vitro effects of estradiol on the 
stiffness of human fetal osteoblasts and hence the underlying cytoskeletal changes. 
Estradiol was observed to decrease the stiffness of cells through altered F-actin 
structures, which was not influenced by extracellular matrix. Estradiol was also observed 
to increase the differentiation of cells and influence the mineral matrix deposition. The in 
vivo loss of estrogen was achieved using ovariectomized rat models and their effects on 
primary bone cells were also studied. In vivo loss of estrogen caused impaired bone cells 
with increased stiffness with denser actin cytoskeleton, increased differentiation and 
defective matrix synthesis. Primary bone cells from ovariectomized rats were observed to 
vii 
 
be more responsive to in vitro treatment of estradiol than those from normal rats. 
Estradiol treatment on osteopenic bone cells was found to cause decreased stiffness with 
less dense F-actin, increased differentiation, reduced proliferation and improved matrix 
synthesis. Alterations in cytoskeleton and stiffness of osteoblasts could bear implications 
for their mechanosensory functions, as the cytoskeletal structures play an important role 
in mechanotransduction of cells. The assessment on direct in vitro effect of estradiol on 
osteoblasts mechanosensitivity showed that the transient intracellular calcium response 
and terminal nitric oxide release in response to low fluid shear stress was enhanced due to 
estrogen.  
On the other hand, in studying the pathogenesis of postmenopausal osteoporosis 
using ovariectomized animal models, the effects of estrogen deficiency on bone mass and 
micro-architectural changes had been extensively documented before. However, the 
intrinsic tissue-level property at nano scale, which is more reflective of bone remodeling 
activity, was poorly understood. As a part of thesis, the effects of estrogen loss in 
ovariectomized rat models on the tissue level properties were documented extensively in 
terms of various parameters. The results suggest that estrogen loss causes rapid 
deterioration of micro-architecture and densitometry of trabecular bone. Although 
cortical bone densitometry was not adversely affected by estrogen loss, the intrinsic bone 
quality (as measured by nano-level elastic modulus and hardness), viscoelasticity and 
geometry of cortical bone has been adversely affected.  
Taken together, the results of this thesis provide an insight into intrinsic tissue-
level changes and mechanistic cellular changes associated with the pathogenesis of 
postmenopausal osteoporosis.  
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Osteoporosis is a disorder characterized by loss of bone mass and micro-
architecture that often leads to fragility fractures during fall conditions. This loss of bone 
mass usually occurs during aging. Though this disorder existed throughout human 
history, it has become a major health concern only recently, as the human life span 
increases due to advancements in medical field (Lane and Vigorita 1983, Raisz 2005). 
Osteoporosis can be caused by calcium and vitamin D deficiency and 
hyperparathyroidism, but the most common form is the postmenopausal osteoporosis, 
which occurs predominantly in elderly females due to estrogen deficiency (Morgan et al. 
2008, WHO Scientific Group 2003, Lane and Vigorita 1983). The overall aim of this 
thesis is to analyze the effects of estrogen on mechanical and structural properties of bone 
forming osteoblasts cells in vitro and in vivo to better understand the cellular mechanistic 
perspective of the pathogenesis of postmenopausal osteoporosis.  
This chapter starts with a brief introduction on the components and basic 
organization of the bone. Then, the process of bone homeostasis, known as the bone 
remodeling, is explained. The defective remodeling during postmenopausal osteoporosis 
is explained to understand the role of osteoblasts in the pathogenesis of postmenopausal 
osteoporosis. Further to understand the structure – mechanical property relationship of 
the cell, the basic structure of a eukaryotic cell including cytoskeleton, nucleus and their 
interconnections are explained. Then, the biochemical response of osteoblasts to the 
mechanical cues is briefly mentioned. Finally, the idea of using cellular mechanics as a 
marker to study the pathogenesis of osteoporosis will be substantiated. A brief overview 




1.1. The bone organ system 
Bone is a dense, dynamic connective tissue whose structure and construction are 
an ideal compromise between the strength (rigidity) and lightness required to support its 
function to provide mechanical integrity. Apart from providing mechanical strength and 
protection to vital organs of the body, bone is also the primary site for hematopoiesis and 
mineral storage, especially in calcium homeostasis (Bilezikian et al. 2002, Morgan et al. 
2008, Raisz 2005).  
As like any other connective tissue, bone is also composed of cells and the 
extracellular matrix (ECM). However, the cells in bone tissue are much dispersed and 
fewer in number compared to other connective tissues. The major cellular components of 
the bone include osteoblasts, osteocytes and osteoclasts. Osteoblasts are the mono-
nucleated bone forming cells, derived from mesenchymal stem cells. These cells 
synthesize the protein matrix of bone composed of type I collagen and other non-
collagenous proteins (osteoid), which creates the template for mineralization and mature 
bone formation. In a mature bone, osteoblasts are found lining the bone matrix, covering 
the available bone surface. Osteocytes are those osteoblasts that further undergo 
differentiation when encased in the osteoid bone matrix synthesized by it. They escape 
apoptosis and reduce the synthesis of matrix proteins. They further develop long 
processes that extend through the lacunocanalicular system of bone, forming an 
interconnected network that allows intercellular communication with the neighboring 
osteocytes and the surface-lining osteoblasts. Osteoclasts are the large multi-nucleated 
bone resorbing cells derived from hematopoietic mono-nucleated cells. In bone, they are 
found in shallow depressions on bone surface called Howship’s lacunae. A mature 
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osteoclast is formed by fusion of cells from hematopoietic and myelomonocytic origin. 
Osteoclasts are assumed to be a specialized type of marcrophage because these cells 
employ the same cellular machinery, as that of phagocytosis, for bone resorption 
(Bilezikian et al. 2002, Morgan et al. 2008).  
In materials aspect, bone is considered as a composite material comprising of both 
inorganic and organic phases, apart from the cells. By weight, approximately 60% of the 
bone is made of inorganic matter, 8-10% is water and the rest is organic matter. By 
volume, these proportions are approximately 40% inorganic, 25% water and 35% organic 
matter. The inorganic phase of the bone offers the required stiffness for the bone. It is 
mainly composed of hydroxyapatite, which is a natural form of calcium phosphate. The 
small plate-shaped apatite crystals contain impurities; most significantly carbonate 
replacing the phosphate groups. The presence of carbonate makes bone mineral similar to 
dahllite, a carbonate apatite. Other known impurities include potassium, magnesium, 
strontium and sodium substitutions for calcium ions and chloride and fluoride for 
hydroxyl groups. These impurities reduce the crystallinity of bone mineral, and 
subsequently the solubility. The organic phase of bone is very important for it influences 
the structure, mechanical and biomechanical properties of the bone. Type I collagen is the 
major structural component of the bone matrix, comprising 98% of the total organic 
phase. Collagen is a very rigid linear molecule approximately 300 nm long and confers 
the required strength to the bone. Osteonectin, ostopontin, osteocalcin, bone sialoprotein, 
proteoglycans and other phosphoproteins and phospholipids form the remaining 2% of 
the organic phase of the bone and they are vital for biological function (Bilezikian et al. 
2002, Morgan et al. 2008).  
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Macroscopically, at the scale of 1-10 mm, two types of bone can be distinguished. 
Cortical or the compact bone forms the hard outer layer, forming 80% of bone mass. In 
human bone, the basic functional unit of the compact bone is called the osteon or the 
Harversian system, which are cylindrical structures, 200 µm in diameter and 1-3 mm in 
length. Vascularization of bone is through the blood vessels that pass through the center 
of these osteons, through a canal called Harversian canal. The osteons transversely 
connect to adjacent osteons through Volkmann’s canal that provide a radial path for 
blood flow. The porosity of the compact bone ranges from 5-20%. This porosity is due to 
the presence of Harversian and Volkmann’s canals and to a lesser extent, the lacunar and 
canalicular spaces, where osteocytes reside in. Trabecular or the cancellous bone forms 
the remaining 20% of bone mass. It is a highly porous structure consisting of network of 
rod- and plate-shaped trabeculae surrounding an interconnected pore that is filled with 
bone marrow. The porosity of trabecular bone can range from 40-95%. The thickness of 
trabeculae ranges from 50-300 µm. The microarchitecture of trabeculae varies among the 
anatomic sites. The trabecular bone is composed of lamellar bone arranged in packets, 
known as the hemiosteons. Lamellar bone and woven bone are microscopic 
differentiation of growing bone. While woven bone has randomly arranged mineralized 
collagen fibrils, lamellar bone is more mature form of bone tissue with plywood like 
arrangement of aligned sheets of collagen fibrils (lamellae) (Morgan et al. 2008).  
Sex steroids are known to play an important role on bone physiology. They 
participate in sexual dimporphism of skeleton, play an important role in mineral 
homeostasis during pregnancy and lactation and are essential to maintain bone balance in 
adults (Turner et al. 1994). Hypogonadism in either sex is associated with rapid bone 
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loss, which is preventable with gonadal steroid replacement (Monroe et al. 2006). 
Elevated sex steroid levels during puberty causes increased rate of skeletal growth in both 
sexes. During adolescence, sex steroids influences bone metabolic processes resulting in 
a combination of increases in bone length, diameter, cortical bone width and cancellous 
bone mass. Apart from this direct effect on bone metabolism, sex steroids also play an 
important role in calcium homeostasis. The increased production of estrogen during the 
last three months of pregnancy was associated with increased calcium absorption from 
mother’s bone for the formation of fetal skeleton. The increased demand of calcium in 
pregnant women is largely met by doubling maternal calcium absorption beginning as 
early as 12 weeks of gestation (Clarke and Khosla 2010). Postmenopausal loss of 
estrogen in elderly women was known to cause increased risk of osteoporotic fractures 
due to poor bone strength (Raisz 2005). Thus, sex steroids are important for skeletal 
development and mineral homeostasis at different stages of human life. 
1.2. Bone remodeling 
The Bone tissue is dynamic that it is constantly being broken down and rebuilt. 
Healthy bones require continuous modeling and remodeling to fulfill the diversified 
structural functions of the bone.  It is estimated that approximately 10% of the skeleton is 
being renewed every year by the remodeling process (Lerner 2006). Although bone 
remodeling occurs at the surface of the cortical and trabecular bone, the rate of trabecular 
remodeling is usually 5-10 times higher than the cortical bone remodeling rates in adult. 
This explains why metabolic bone diseases such as osteoporosis are mostly observed in 
bones with higher amounts of trabecular bone, such as the wrist, vertebrae and hip bones 
(Lerner 2006). Bone histology shows that the bone is composed of individual structural 
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units called bone metabolic unit or bone multicellular unit or basic multicellular unit 
(BMUs), where the functionally coupled osteoblasts-osteoclasts cells are present and the 
bone remodeling takes place (Morgan et al. 2008, Lerner 2006, Jilka 2003). It is 
estimated that human skeleton consists of one to two million BMUs. While the BMUs 
regulate the local balance of formation and resorption of bone, this system has also 
evolutionarily adapted to respond to global mechanical forces and systemic metabolic 
requirements (Riggs and Parfitt 2005).  
Bone homeostasis is maintained by the coordinated activity of bone-forming 
osteoblasts and bone-resorbing osteoclasts. Osteoblasts influence osteoclast formation 
and activity, which in turn influences osteoblasts differentiation and activity. This 
concept is referred to as ‘coupling’ (Bilezikian et al. 2002, Morgan et al. 2008). The 
majority of cytokines, expressed by osteoblasts such as macrophage colony stimulating 
factor (M-CSF), receptor activator of nuclear factor κ ligand (RANKL) and 
osteoprotegrin (OPG), are found to regulate the differentiation of osteoclasts progenitor. 
The pre-osteoblasts cell, which is formed by the differentiation of mesenchymal stem 
cells, synthesizes M-CSF and RANKL, while differentiating into osteoblasts. Thus, when 
the osteoblasts begin to mature into matrix producing cell, it signals the hematopoietic 
progenitor cells to differentiate to osteoclast precursor cells through the expression of M-
CSF and further differentiation of osteoclast precursors to mature osteoclasts through the 
expression of RANKL (Morgan et al. 2008, Bilezikian et al. 2002, Lerner 2006). It is also 
widely believed that osteoclasts signal the osteoblasts progenitors by releasing the bone 
morphogenetic proteins (BMPs) and other growth factors such as insulin growth factor-I 
(IGF-I) and transforming growth factor-β (TGF-β) (Morgan et al. 2008, Lerner 2006). 
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According to the model proposed by Parfitt, there are five stages in the 
remodeling process, namely quiescence, activation, resorption, reversal and formation of 
new bone, continuing to quiescent stage, which then goes through another cycle of 
remodeling. Figure 1.1 shows the physiological remodeling stages in a BMU.   
 
 
Figure 1.1. Physiological remodeling of bone in a BMU: A. Osteoblasts lining the bone 
surface that includes osteoid layer and the mineralized bone matrix (quiescence) B. 
osteoblasts resorb the osteoid layer, detach from bone surface, send signals for maturation 
of osteoclasts followed by osteoclasts recruitment on bone surface and formation of 
resorption lacunae by osteoclasts (Activation and Resorption) C. Detachment of 
osteoclasts from lacunae followed by formation of cementum line by cleaning cells 
(Reversal) D. Recruitment of osteoblasts at the surface of resorption lacunae followed by 
formation of new bone (Formation) E. Formation of osteoid bone with surface lining 
osteoblasts (back to quiescence) (Morgan et al. 2008) (Figure adapted from Lerner 2006) 
 
The bone surface is covered by a thin layer of flattened cells, which are the 
terminally transformed osteoblasts cells. These surface lining osteoblasts have receptors 
for molecules like estrogen, parathyroid hormone (PTH) and Prostaglandin E2 (PGE2). 
Osteoblasts may respond to such substances or other signals for remodeling (such as 
mechanical loading, microdamage etc.) by resorbing the unmineralized bone surface 
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(osteoid) beneath the lining cells, exposing the mineralized bone (Morgan et al. 2008). 
The activation sequence of bone remodeling is thus initiated. Activation begins by 
recruiting osteoclasts on the mineralized bone surface. Increased expression of RANKL 
and M-CSF and decreased expression of OPG by the osteoblasts and its progenitors helps 
in the differentiation of osteoclasts progenitors to mature osteoclasts. The attachment of 
osteoclasts to the mineralized bone surface is achieved by binding of vitronectin receptors 
of osteoclasts to the proteins with RGD aminoacid sequence, such as osteopontin, 
osteocalcin and osteonectin, exposed at the surface of mineralized bone (Lerner 2006). 
Thus, osteoclasts cannot adhere to unmineralized bone and are capable of resorbing only 
mineralized bone. The retraction of surface lining osteoblasts from the bone surface and 
the attachment of osteoclasts on the mineralized bone leads to the resorption of bone by 
the osteoclasts (resorption phase), resulting in the formation of resorption lacunae. The 
reversal phase is the time interval between the completion of resorption and initiation of 
bone formation at a specific BMU, which normally takes about 1-2 weeks (Morgan et al. 
2008). The whole process from the initiation of remodeling to reversal takes about 2-4 
weeks (Lerner 2006). During the reversal phase, the osteoclasts leave the resorption 
lacunae and certain less-well-characterized mononuclear cells appear in the lacunae and 
clean up the organic matrix. It is also believed that these cleaning cells possibly form a 
more intensively stained cementum line in the bottom of the lacunae (Everts et al. 2002). 
Subsequently, osteoblasts precursor cells are recruited at the lacunae, where they 
differentiate into mature osteoblasts.  These osteoblasts fill the resorption lacunae with 
the new bone (formation phase) and the bone reverts to quiescent stage. The bone 
formation and completion of the remodeling at the BMU takes 4-6 months (Lerner 2006).  
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1.3. Pathogenesis of postmenopausal osteoporosis 
Postmenopausal osteoporosis is characterized by increased bone remodeling 
resulting from estrogen deficiency in elderly woman following menopause. Estrogen 
plays an important role in male skeleton also (Syed and Khosla 2005). Postmenopausal 
woman has increased number of BMUs in their bone (Lerner 2006). Two important 
factors for normal remodeling resulting in a healthy homeostasis of bone are the 
activation frequency and algebraic difference between the formation and resorption 
phases. Activation frequency refers to the statistical probability that bone remodeling will 
be initiated on any bone surface at any given time (Riggs and Parfitt 2005). This 
activation frequency is highly different in the diseased skeleton. When the formation is 
lower than resorption, it will result in a decreased ability of osteoblasts to fill the 
resorption lacunae. This will contribute to unbalanced remodeling that will eventually 
lead to decrease in bone mass (Lerner 2006). Increased frequency of BMU activation in 
postmenopausal women leads to an increase in the number of osteoclasts and hence, the 
number of resorption lacunae on the bone (Figure 1.2). This will result in increased levels 
of calcium and deoxypyridinoline crosslinks (collagen degradation products) in urine. 
These are the by-products of bone resorption process. With the increase in bone 
resorption, bone formation sites also increases, resulting in increased levels of serum 
osteocalcin (Figure 1.2), which is the widely used marker for bone formation in vivo. 
Osteocalcin is synthesized by osteoblasts and recruited into the bone matrix during bone 
formation. Although both osteoblasts and osteoclasts are increased in number, the 
increased frequency of activation together with the decreased ability of osteoblasts to 




Figure 1.2. Comparison of bone remodeling in normal bone and postmenopausal 
osteoporosis (Figure adapted from Lerner 2006) 
 
If we look more in to cellular aspects, both osteoblasts and osteoclasts carry the 
receptors for estrogen (ER). As like any other steroid receptor, ERs are ligand-dependent 
transcription factors located in the cytosol of the cell. Upon estrogen binding to the 
receptor, they dimerize and translocate into the nucleus, where they regulate the 
transcription of genes. Since both osteoblasts and osteoclasts express estrogen receptors, 
estrogen is expected to have a direct effect on the bone cells and hence the bone 
remodeling (Lerner 2006). Also, the estrogen receptors in the mature osteoclasts are 
proved to be functional and known to control the bone resorbing activity (Oursler et al. 
1991, Hughes et al. 1996, Chen et al. 2005, Taranta et al. 2002). Estrogen is known to act 
on downstream of the RANKL activation pathway of osteoclasts (Srivastava et al. 2001, 
Shevde et al. 2000). Osteoblasts are crucial for osteoclastogenesis. Osteoblastic 
expression of M-CSF, RANKL and OPG, activation of estrogen receptors in osteoblasts 
also play a role in the differentiation of osteoclasts precursors. Estrogen and its analogs 
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are known to increase the OPG expression in both mRNA and protein levels in human 
osteoblasts and murine stromal cells (Hofbauer et al. 1999, Saika et al. 2001). Although 
there is no direct effect of estrogen on RANKL expression, estrogen is known to act on 
the RANKL stimulating cytokines. Estrogen may also influence the osteoclastogenesis by 
down regulating the expression of M-CSF (Lea et al. 1999). Thus, the pathogenesis of 
osteoporosis occurs through the effects of estrogen deficiency on the osteoblasts and 
osteoclasts. 
At cellular level, there are considerable evidences to show that estrogen directly 
regulates the proliferation and differentiation of osteoblasts. Both estrogen and 
testosterone prolong the lifespan of osteoblasts by inhibiting osteoblasts apoptosis 
(Kousteni et al. 2001, Syed and Khosla 2005). Thus, the deficiency of estrogen will result 
in accelerated osteoblasts apoptosis. Also, estrogen inhibits the cytokines (Interleukin-I 
and tumor necrosis factor-α) which stimulates the apoptosis of the osteoblasts. The effect 
of estrogen on osteoblasts apoptosis is mediated through the activation of Src/Shc/ERK 
signaling pathway and downregulation of JNK (Kousteni et al. 2001). Estrogen is also 
known to stimulate the expression of type I collagen. Thus, during estrogen deficiency, 
osteoblasts will become impaired in producing the bone matrix (Ireland et al. 2002, Ernst 
et al. 1988).  
Thus in postmenopausal women, estrogen deficiency has a direct effect on 
osteoblasts and osteoblasts-mediated effect as well as direct effect on osteoclasts cells 
resulting in defective bone remodeling and subsequent loss of bone mass. Thus, it is 
important to study the effects of estrogen on osteoblastic cells to better understand the 
pathogenesis of osteoporosis. 
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1.4. Basic structure and mechanical properties of a eukaryotic cell 
Before we study the structure-property relationship of the osteoblastic cells, it is 
important to understand the structural components of a eukaryotic cell. Cell is the basic 
functional unit of life. In engineering aspects, cell can be considered as a delicately 
designed machine with complicated functional components. A cell is basically composed 
of different cellular organelles, enclosed inside a plasma membrane. Each cellular 
organelle is known to perform a unique function. The basic structure of a eukaryotic cell 
and its different organelles are shown in Figure 1.3.  
The plasma membrane is a semi-permeable lipid bilayer that encloses the whole 
cell and separates it from the extracellular environment. The membrane bound organelles 
include nucleus, mitochondria, Golgi apparatus, endoplasmic reticulum (rough and 
smooth), centrioles, ribosomes, lysosomes etc. that are dispersed in the cytosol (or the 
intracellular fluid). Certain proteins of cytosol form an interconnected scaffolding 
network that connects the nuclear structural proteins to the cell adhesion molecules at the 
plasma membrane and to the extracellular matrix. This cell scaffold is known as the 
cytoskeleton. The dynamic nature of these cytoskeletal proteins helps the cell to maintain 
its shape. They also play an important role in the interaction with the extracellular matrix 
and intracellular transport of molecules and signals. The cytoskeletal structures are also 













The cytoskeleton of the cell includes 3 types of filamental proteins, namely the 
microfilaments, intermediate filaments and the microtubules. The integral network of the 
cytoskeleton plays an important role in determining how a cell responds to mechanical 
stress (Houben et al. 2007). The schematic representation of the cellular structures 
involved in the maintenance of the mechanical integrity of the cell is shown in Figure 1.4.  
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Figure 1.4. Schematic representation of cellular structures involved in maintaining the 
mechanical integrity of the cell (Houben et al. 2007) 
 
As shown in the figure, the three cytoskeletal components are the key elements in 
linking the cellular surface to the nucleus. Cell adhesion proteins, such as cadherins and 
integrins, bind to the cytoskeleton through linker proteins. The cytoskeleton, on the other 
end, interacts with the nucleus. The cadherin and integrins directly interact with the 
adjacent cells and the extracellular matrix proteins. All these elements form a pre-stressed 
scaffold that can withstand mechanical stress. Also, this physically connected network of 
protein is hypothesized to receive the mechanical signals via the adhesion molecules and 
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transmit the signals directly to the nucleus to regulate stress associated gene expression 
(Houben et al. 2007). This process is known as mechanotransduction. Thus, changes in 
cytoskeleton results in changes in the overall mechanical property of the cells, thereby 
affecting the physiological function of the cell. The mechanical property of cells are thus 
regulated by mechanical forces exerted by the structure of cytoskeleton, its connection to 
neighboring cells and the substratum (extracellular matrix) (Ingber et al. 1994, Li et al. 
1987). When mechanical forces exerted on a cell change, cytoskeletal changes can occur. 
This can influence the cell growth, cell cycle progression and gene expression. So, the 
changes in the mechanical integrity, generated by changes in cytoskeletal structures, are 
connected to disability in carrying on the normal physiological functions of the cell 
(Singhvi et al. 1994, Ingber et al. 1995, Ingber 1993). Thus, studying the mechanical 
behavior of the cell is recently becoming a new approach to study the pathogenesis of 
diseases. 
Most of the research focuses on studying the molecular, microbiological, 
immunological and pathological aspects of studying human diseases. Very less focus was 
given on the mechanical basis of the disease which might make direct contributions to 
symptoms and pathophysiological outcomes of the disease. For instance, the pathogenesis 
of certain diseases, such as cancer, malaria, sickle cell anemia, spherocytosis, 
elliptocytosis, arthritis etc., has been proved to originate from structural and mechanical 
property changes of the cells and their abnormal mechanotransduction (Lim et al. 2006, 
Ingber 2003, Lee and Lim 2007). Thus, nanobiomechanics, which is the study of the 
mechanics of living cells and biomolecules and their connection to human diseases, is 
becoming a valuable tool to study the pathogenesis of diseases.  
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1.5. Importance of mechanics of bone cells 
As previously mentioned, the most important function of bone is to provide 
mechanical integrity. Bone is subjected to a variety of forces every day. It not only 
functions to withstand those mechanical forces, but also responds dynamically to the 
different forces with changes in size, shape and density. Earlier in 1892, this phenomenon 
was described by the German scientist, Julius Wolff. Known by the misnomer, the 
Wolff’s law states that “the form of a bone being given, the bone elements place or 
displace themselves in the direction of functional forces and increase or decrease their 
mass to reflect the amount of the functional forces” (Wolff 1892). This implies that bone 
remodeling occurs more at the places exposed to higher functional forces.  
If we look at the meaning of Wolff’s law at cellular level, it implies that the bone 
cells are capable of responding to mechanical forces and initiate bone remodeling 
according to the magnitude of force exerted on it. Osteoclasts do not form a part of bone 
organization, but are recruited at the bone surface only during bone resorption phase. But, 
osteoblasts and osteocytes form a part of bone organization with osteoblasts lining the 
surface of the bone and osteocytes interspersed in the bone matrix. Either the osteoblasts 
sense the force itself and signal for remodeling or the osteocytes sense the force and 
signal the osteoblasts to initiate the bone remodeling. The prevailing view is that when a 
mechanical force is exerted by the bone, it causes the streaming of interstitial fluid. This 
interstitial fluid flow imposes shear stress on the surface lining osteoblasts and the also 
the osteocytes. It has been shown that bone cells respond to fluid shear much like 
endothelial cells but the sensitivity to fluid shear is much higher in bone cells (Reich et 
al. 1990). This results in the initiation of bone remodeling and building up of bone mass.  
19 
 
Thus, bone has been intrinsically designed to respond and adapt to changes in 
mechanical loads through changes in bone remodeling. For bone diseases, such as 
osteoporosis, which is caused by impaired bone remodeling characterized by the 
deviation in the dynamic balance of osteoblasts and osteoclasts activity, it is important to 
study the mechanical basis of the disease. Studying mechanical property of the 
osteoblastic cells along with their sensitivity to mechanical forces will help us to better 
understand the pathogenesis of osteoporosis. 
1.6. Objectives and overview of thesis 
As explained in the previous sections, bone cell mechanical property and 
mechanosensitivity are also important for the physiological functions of the cells. Being 
the structural and functional component of bone tissue, osteoblasts mechanical property is 
important for the function of the cell and the tissue. The central aim of this thesis is to 
study the changes in mechanical and structural properties and mechanosensitvity of 
osteoblasts associated with estrogen that could help us to better understand the 
pathogenesis of osteoporosis in a mechanistic perspective. 
1.6.1. Clinical significance 
The world health organization defines osteoporosis as the pathological condition 
when the bone density T scores, as determined by dual energy X-ray absorptiometry 
(DXA), at or below 2.5 standard deviations of the normal peak values for young adult. 
Clinically, osteoporosis is defined as the skeletal disorder characterized by compromised 
bone strength predisposing the person to an increased risk of fracture. Though 
osteoporosis can be caused by calcium and vitamin D deficiency and 
hyperparathyroidism, the most common form is the postmenopausal osteoporosis which 
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occurs predominantly in elderly females due to estrogen deficiency. Estrogen deficiency 
triggers an increase in bone remodeling, which is characterized by increased osteoclastic 
activity (bone resorption), and a relative deficit in osteoblastic activity (bone formation). 
This causes rapid loss of bone mass, resulting in osteoporosis.  As seen in pubertal 
growth spurt, high rates of bone resorption not always cause osteoporosis. Therefore, the 
basic reason for the cause of osteoporosis could be the inadequate osteoblastic activity to 
balance the osteoclastic activity. Thus, this study chooses analyze the changes in the 
osteoblasts during the pathogenesis of osteoporosis, in terms of the changes in the 
mechanical properties of the cell. 
Osteoporosis is becoming a major health concern, mainly affecting the people 
over the age of 50 years. With the advancements in health care, the average life 
expectancy is increasing. On the other hand, the quality of life of elderly population is 
reduced because of osteoporosis and the fragility fractures. With the increase in average 
life span of human beings, osteoporosis is increasingly becoming a serious health issue. 
About 98% of hip fractures occur in elderly population, due to osteoporosis. It is 
predicted that the estimated number of hip fractures worldwide would rise from 1.7 
million in 1990 to 6.3 million in 2050 (WHO Scientific Group 2003).  Lots of research 
focuses on developing new drugs for the treatment of osteoporosis. Presently there are 
two major classes of drugs for the treatment of osteoporosis, namely the anti-resorptive 
and anabolic drugs. Within the next few years, several new drugs are likely to be licensed 
for use in the treatment of osteoporosis. But, drug discovery and development of new 
drugs is an extremely time-consuming process. It usually takes at least 10 years for 
testing a new drug experimentally for safety and clinical trials. In this scenario, the 
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outcome of this thesis would help us better understand the pathogenesis of osteoporosis 
and establish a new method for testing osteoporotic drug efficacy. A new proposed drug 
component can be tested on osteoporotic rat osteoblasts for its efficacy to restore the 
mechanical properties. A better understanding on the pathogenesis of osteoporosis would 
also help us device new drug components for the treatment of osteoporosis. 
1.6.2. Novelty 
The pathogenesis of osteoporosis has long been studied on the basis of tissue-
level mechanical properties of bone and cellular-level mechanisms of osteoblasts and 
osteoclasts cells. The pathogenesis was understood on cellular basis as over powered 
activity of bone resorbing osteoclasts compared to the bone forming osteoblasts resulting 
in deterioration of bone mass. However, this does not explain the changes in the complex 
micro-architecture of bone, which includes mineral, inorganic and organic components 
with interspersed osteocytes and lining osteoblasts cells. The changes in mechanical 
behavior of these cellular components of bone, which can potentially affect the tissue 
level mechanical properties of bone, have not been accounted so far. This is the first 
study to aim at approaching the pathogenesis of osteoporosis in terms of cellular level 
mechanical properties of the osteoblasts cells. 
1.6.3. Specific objectives 
 The overall objective of the thesis is to study the estrogen dependent changes in 
the mechanical property of osteoblasts both in vitro and in vivo, and analyze the 
underlying structural and functional changes of the osteoblasts to better understand the 




The specific objectives of the study are as follows: 
 To analyze the direct effect of estrogen on the mechanical and structural properties of 
the commercially available human fetal osteoblasts cell line, hFOB 1.19.   
 To study the ovariectomy induced tissue-level bone property changes in terms of 
micro-architectural, densitometric, geometric, mechanical and intrinsic tissue 
properties 
 To investigate the changes in mechanical, structural and functional properties of 
osteoblastic cells isolated from normal and ovariectomized rat models.  
 To analyze the direct effect of estrogen on the mechanosensitivity of osteoblastic cells 
in terms of intracellular calcium and nitric oxide expressions. 
 
The brief overview of this thesis is given in the following flow chart (Figure 1.5).  
The direct effect of estrogen on bone cell in vitro and the in vivo effect of 
ovariectomy on the isolated primary bone cells were characterized in terms of elastic 
modulus measured from Atomic Force Microscopy (AFM)-force indentation, 
cytoskeletal changes, proliferation, mineralization and alkaline phosphatase activity. The 
effect of ovariectomy on tissue-level properties of the bone was extensively studied in 
terms of changes in micro-architectural, densitometric, geometric, mechanical and 
material properties. The effect of in vivo loss of estrogen, induced by ovariectomy, on the 
mechanical, structural and functional property of the isolated primary osteoblasts was 
studied. The direct effect of estrogen on the mechanosensitivity of osteoblasts cells was 






























 In this chapter, we will first review on various important methods used in this 
thesis. Following that the literature information on the ovariectomized rat models and 
human fetal osteoblasts cell line, used in this study is reviewed. Later, we will review the 
current studies on the in vitro cellular and molecular effects of estrogen on osteoblasts 
cells and the in vivo effects of ovariectomy on the bone tissue and bone cells. The 
mechanical properties and mechanotransduction of osteoblasts cells will also be 
reviewed. 
2.1. Review on the materials and methods 
2.1.1. Atomic Force microscopy 
Atomic force microscopy (AFM) was employed in this thesis to investigate 
cellular mechanical properties of osteoblastic cells under different conditions. Invented in 
1986 by Binning et al. (Binning and Quate 1986), AFM soon became a valuable and 
useful tool for imaging and as a force sensor with piconewton force resolution. One 
major advantage of AFM imaging is that it enables us to study the live cells in native and 
physiological environment, without staining the cells or placing them in high vacuum. 
This makes AFM a powerful tool to image soft biological samples in their native form. 
On the other hand, AFM is also used to probe the micromechanical properties of soft 
living cells in their physiological environment and also to study the force interactions 
between different biomolecules. 
The schematic diagram of the AFM equipment set up is shown in Figure 2.1. The 
equipment consists of a very sharp tip (or stylus) mounted at the end of a flexible 
cantilever of a very low spring constant. The tip is directly in contact with the sample 
surface. A computer controlled piezoelectric scanner is used to precisely control the 
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relative position of the sample and the tip. The interaction force between the tip and the 
sample surface causes deflection of the cantilever which is recorded by the laser beam 
reflected from the back of the cantilever. The changes in the position of the reflected laser 
beam are captured using a sensitive four sectioned photodiode, whose signals are then 
processed by the computer. By raster scanning the surface of the sample, high nano-scale 
resolution image can be obtained. Also, the piconewton scale interaction forces between 
the tip and the sample surface can be measured using AFM, which makes it suitable for 
studying molecular interactions and cellular mechanical properties (Lim et al. 2006, 
Morris et al. 1999). 
 
 
Figure 2.1. Schematic diagram of AFM machine (Lim et al. 2006) 
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2.1.1.1. AFM imaging of cells 
Topographical imaging using AFM offers numerous advantages: AFM yields 
topographical maps with a very good vertical resolution; it does not require extensive 
sample preparation, staining or labeling; it offers resolution at sub-nanometer range and it 
allows visualization of biological sample under physiological conditions by preserving 
their structure and function over longer time period (Duman et al. 2012). AFM was used 
to study the morphology of fixed cells (Braet and Wisse 2012, Pesen and Hoh 2005, 
Moloney et al. 2004, Sinniah et al. 2002, Weyn et al. 1998, Pietrasanta et al. 1994, Le 
Grimellec et al. 1994, Braet et al. 1998) as well as live cells (Braet and Wisse 2012, 
Pesen and Hoh 2005, Sinniah et al. 2002, Braet et al. 1998, Li et al. 2009, Bushell et al. 
1999, Hofmann et al. 1997, Le Grimellec et al. 1998, Hoh and Schoenenberger 1994, 
Henderson 1994) with high resolution. It was also proven to be effective in the study of 
cellular dynamics (McNally and Borgens 2004, Chen et al. 2004, Ushiki et al. 1999).  
Although live cell imaging is quite challenging due to the soft nature of the cells, 
MDCK cells (Le Grimellec et al. 1994, Hoh and Schoenenberger 1994), colon carcinoma, 
skin fibroblasts and liver macrophages (Braet et al. 1998), human fibroblast (Bushell et 
al. 1999), rabbit corneal fibroblast, conjuctival cells, fenestrated liver sinusoidal 
endothelial cells (Braet and Wisse 2012) and transformed human corneal epithelial cells 
(Sinniah et al. 2002), chicken cardiocytes (Hofmann et al. 1997),  kidney cells (Le 
Grimellec et al. 1998) were successfully imaged under live condition using AFM. Studies 
were being carried out to improve the live cell imaging technique using AFM by limiting 
the indentation force to 20-50 pN and indentation depth to less than 10 nm (Le Grimellec 
et al. 1998). Improving the cell adhesion to the substrate by substrate activation is also 
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proven to improve the quality of live cell imaging (Bushell et al. 1999). Live cell imaging 
is particularly difficult when the cells do not adhere well to the substrate. Based on this, 
Muys et al. (2006) proposed a technique called “bioimprinttrade mark”. In this technique, 
the biological cells are printed onto non-biohazardous polydimethylsiloxane (PDMS) 
mold, and the captured replica impression of the cells is imaged using AFM (Muys et al. 
2006). 
The dynamic morphological changes in the live cells were also investigated using 
AFM. By combining the AFM with a fluid chamber that provides regular supply of 
medium and maintains temperature, Ushiki et al. (1999) studied the dynamic changes in 
the cells during the cell movement in a long time window (Ushiki et al. 1999). AFM was 
also used to investigate the dynamic changes associated with single tumor cell division. 
Chen et al. (2004) documented these dynamic changes along with the ultrastructure of 
live bladder cancer cells that can elucidate the mechanism of malignant transformation of 
normal bladder cells (Chen et al. 2004). In neural cells, AFM was used to study the real 
time changes in the death process of neuron following a physical manipulation and also 
to image the dynamic changes in the morphology of developing neurons (McNally and 
Borgens 2004). Although AFM had been used for studying dynamic changes of certain 
living cell processes, the time scale of most biological processes was shorter than the 
time required to record a high resolution image using the conventional AFM (several 
seconds to minutes per frame). The recent development of high-speed atomic force 
microscopy (HS-AFM) by Ando et al. (Ando et al. 2001, Ando 2012, Ando 2013) 
involved miniaturization of cantilever and scanning stage that reduces mechanical 
response time of the feed-back system, preventing the onset of resonant motion during 
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high-speed imaging, thereby achieving scanning speed of up to 33 frames per second. 
HS-AFM has been successfully used to study the dynamic structural and functional 
changes of biomolecules such as proteins and their interactions in living cells (Yamashita 
et al. 2012, Casuso et al. 2012, Rajendran et al. 2012). 
On the other hand, the cells can be fixed and then imaged using AFM. Fixed cells 
can be imaged under dry or wet conditions. Cells dried after fixation showed flattening 
cytoplasm and loss of nuclear structure but retained the cytoskeletal structures, whereas, 
wet fixed cells showed an overall rounding morphology and ill-defined structure (Braet 
and Wisse 2012, Weyn et al. 1998). Cellular components such as mitochondria, 
cytoskeleton, nucleus and even nucleolus was imaged using AFM under high resolution, 
by dry fixation of cells followed by digestion of plasma membrane (Pietrasanta et al. 
1994). Overall, AFM has been serving as a powerful tool for biologists to study cellular 




2.1.1.2. AFM force indentation to measure cell mechanical properties 
AFM has the potential to measure the localized mechanical properties of the cell. 
One of the greatest advantages of AFM over other techniques for cell mechanics is the 
capability of combining high-resolution scanning with nanoindentation, thereby studying 
the spatial distribution of cell mechanical properties and correlating the local mechanical 
properties with the underlying cytoskeletal structures. AFM has also been widely used to 
study the nanomechanical properties of biomolecules, especially proteins (Kurland et al. 
2012). The overall mechanical property of a single cell has been gaining interest recently, 
as it is also widely believed that the mechanical property of the cells obtained from AFM 
also serves as a disease marker (Costa 2006, Lee and Lim 2007, Costa 2003). 
For mechanical analysis using AFM, either a sharp tip (Lieber et al. 2004, Rotsch 
et al. 1999, Rotsch et al. 1997) or a spherical probe (Smith et al. 2005, Mahaffy et al. 
2004) can be used. While the pyramidal sharp tip is used to probe the localized 
mechanical properties of cellular structures on a nano-length scale, spherical bead probes 
of varied sizes were used to measure bulk mechanical properties of the cells on a larger 
length scale. A steel spherical probe of radius 18 µm was used to measure the elastic 
modulus of polystyrene, polymethylmethacrylate and PDMS (Lin and Kim 2012). 
Lulevich et al. used the microsphere modified AFM probes to compress the cell and 
measure the reaction force. The force deformation curve showed a cubic relationship for 
small deformations less than 30% and had multiple peaks for deformations in the range of 
30% to 70% (Lulevich et al. 2006). Rheological properties were also measured using 
AFM by using the spherical probe to stretch the cells (Canetta et al. 2005).  
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Lots of research also focuses on the interpretation of the experimental results from 
AFM. An immediate outcome of a single AFM indentation is a force-displacement curve, 
from which the elastic properties of the samples are calculated. The force curve can be 
obtained for every local point of the sample, enabling us to measure the local mechanical 
properties at different regions. The force curve contains information about the force 
interaction between the tip and the sample surface as a function of relative tip-sample 
distance, for a whole cycle of the approach and the retraction of the sample with the tip. 
A typical force curve is shown in Figure 2.2.  
 




The force F, exerted on the cantilever is plotted against the vertical position, Z of 
the sample. The force exerted on the cantilever can be obtained from the cantilever 
deflection by Hooke’s law, F = K*d (K is the spring constant, either provided by supplier 
or found by thermal tune measurements, and d is the deflection in cantilever). Before the 
tip touches the sample surface, the cantilever will not be deflected and no force will be 
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experienced by the cantilever. Thus F equals to zero at the start of the approaching cycle. 
When the position Z of the sample increases, the tip-sample distance will decrease and at 
some point, the tip will touch the sample. After this, raising the sample position will 
result in deflection of the cantilever and hence the force exerted on the cantilever. This 
part of increasing force values along with Z values is known as the region of constant 
compliance (Sokolov 2007). When the force reaches the threshold, set by the operator, 
the sample stops and starts retracting down (Z value decreases). The force curve up to 
this point is called the approaching curve, and after this point, when the sample retracts 
from the tip, is known as retracting curve. Due to adhesion forces exerted by sample and 
tip during retraction of the tip from sample surface, there is slight hysteresis in the 
retraction curve compared to the approaching curve (Morris et al. 1999, Sokolov 2007). 
While using a spherical tip, the most prevalent method of analyzing AFM 
indentation data is using the Hertz model of contact (Weisenhorn et al. 1993, Sneddon 
1965). It is also worthwhile to note that Hertz model has lots of simplifying assumptions 
including infinitesimal deformation of a semi-infinitely thick and flat sample, having 
homogeneous, isotropic and linear elastic material properties and using an axisymmetric 
indenter (Johnson 1987, Costa 2006, Costa and Yin 1999). Hertz-Sneddon’s equation is 
now widely used to determine the elastic modulus of the biological samples from the 
AFM force curves (Li et al. 2008, Lim et al. 2006, Sokolov 2007, Bacabac et al. 2008, 
Tatyana et al. 2007, Lekka et al. 1999, Charras et al. 2001, Jaasma et al. 2006). The 
equation is given below. 
  * 3/24 3RF h E h                       (2.1) 
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The Sneddon’s equation connects the force F with indentation depth h. R is the 
radius of the indenting probe and E* is the apparent elastic modulus. The Z position, 
deflection (d) and indentation depth (h) and their inter-relation are illustrated in Figure 
3.4. Indentation depth (h) is calculated as the difference between Z and deflection (d).  
 
Figure 2.3. (A) Schematic diagram of initial experimental set up for cell indentation 
using probe of diameter 4.5 µm (B) Illustrating the relationship between the indentation 
depth (h), Z position and cantilever deflection (d) (Li et al. 2008) 
 
The absolute elastic modulus of the sample (E) can be calculated by considering 
Poisson’s ratio (ν) of biological sample as 0.5, in the following equation. 







E               (2.2) 
Sneddon’s mechanics has few assumptions. The rigidity of the probe is considered much 
higher than the sample. The probe penetration is much smaller than radius of probe and 





curve is marked with hysteresis due to adhesion forces between tip and sample surface. 
Therefore, only the approach curve was considered for Sneddon’s equation and not the 
retracting curve (Jaasma et al. 2006, Vinckier and Semenza 1998, Kuznetsova et al. 
2007). 
Non-Hertzian model was also used to capture mechanical properties using AFM. 
Costa and Yin (1999) used finite element model to analyze the factors affecting the AFM 
indentation, such as indentation depth, tip geometry, material nonlinearity and 
heterogeneity. Apparent elastic modulus of the sample was obtained as a function of all 
these factors (Costa and Yin 1999). For examining the subcellular mechanics of human 
aortic endothelial cells, they used another approach called the “pointwise modulus” 
approach. Based on this approach they found out that there are two sets of material 
properties for different regions of the cells. A Young’s modulus of 5.6 ± 3.5 KPa was 
observed in regions of prominent linear structures of F-actin whereas, the adjacent 
regions that lack F-actin, showed a lower Young’s modulus of 1.5 ± 0.76 KPa (Costa et 
al. 2006).   
2.1.2. Nanoindentation to measure intrinsic bone tissue properties 
 In this thesis, nanoindentation technique was employed to measure tissue-level 
property changes of bone due to ovariectomy. As previously mentioned, bone exhibits 
complex hierarchical structure comprising of macro-scale cortical and trabecular 
structure, micro-scale osteon and lamellae structure and nano-scale collagen-
hydroxyapatite crystals. This complex hierarchical structure with micro-components 
undergoing dynamic remodeling, results in complicated mechanical properties of bone 
(Akkus et al. 2004). Bone exhibits viscoelastic nature that arises from the void collapse, 
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densification of cancellous bone and the natural viscoelastic response of collagen as a 
polymer (Garner et al. 2000). Viscoelastic properties of bone were observed to correlate 
with ultimate strength and toughness of the tissue (Yeni et al. 2004). Two common 
experimental methods namely, the dynamic mechanical analyzer and the nanoindentation 
had been used to study viscoelastic properties of bone. 
 Nanoindentation tests had been employed to determine the viscosity (η), elastic 
modulus (E) and hardness (H) of the bone at high resolution of load and displacement 
(Oliver and Pharr 1992). Nanoindentation technique provides an advantage of probing 
tissue mechanical property at a spatial resolution of less than 1 µm (Rho et al. 1997). 
Since the measured modulus and hardness corresponds to the nano-scale of bone, they 
reflect the local material property of bone tissue that undergoes substantial bone 
remodeling. Thus the measured parameters could be indicative of the local remodeling of 
bone tissue (Tai et al. 2007).  The nano-level elastic property can be assessed by different 
approaches such as, quasi-static (Ishimoto et al. 2011), semi-dynamic (Isaksson et al. 
2010) and dynamic loading methods (Pathak et al. 2011). The creep effect of bone under 
constant load, as determined by nanoindentation tests, was analyzed by rheological 
Burger model to measure the creep viscosity (Isaksson et al. 2010). The precursory Voigt 
model had been successfully employed to describe creep characteristics of bone matrix 
during the holding period of indentation (Kim et al. 2010).  
 The viscosity of young and old bone during creep behavior had been assessed by 
Kim et al. (2010). Their study indicated that prolonged creep deformation, as reflected by 
lower viscosity values, can play an important role in long-term degradation of mechanical 
stability of bone (Kim et al. 2010). Nanoindentation has also been successfully used to 
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study the localized nanomechanical properties of normal (Isaksson et al. 2010, Kim et al. 
2010)and regenerating bone tissues (Ishimoto et al. 2011).  Changes in nano-level 
mechanical properties of bone tissue during different pathological states, such as 
osteolysis and osteoporosis (Brennan et al. 2009, Nazarian et al. 2008, Chang et al. 2011, 
Yang et al. 2012), had been assessed using nanoindentation tests. Pathological states of 
bone were found to be associated with changes in the nanomechanical property of bone 
and altered viscosity, indicating that the intrinsic tissue quality had been affected during 
these disease states. 
2.1.3. Ovariectomized rat models 
An animal model is indispensable to study the pathophysiology of human diseases 
and also to test the efficacy and clinical trials of newly discovered drugs. Loss of estrogen 
seems to be the most important mechanism causing bone loss in postmenopausal 
osteoporosis. Ovariectomy, the surgical removal of ovaries, had been the common 
procedure to induce estrogen loss in animal models that in turn leads to series of events 
mimicking postmenopausal loss of bone mass in elderly women. Ovariectomized animal 
models are therefore widely used animal models to study postmenopausal osteoporosis. 
The US Food and Drug Administration (FDA), in its “Guidelines for preclinical 
and clinical evaluation of agents used in the treatment and prevention of postmenopausal 
osteoporosis”, recommends evaluating the potent drug in two different animal species, 
including ovariectomized rats and a non-rodent large animal model which possesses 
Harversian systems and remodeling patterns similar to the human situation (Egermann et 
al. 2005, Thompson et al. 1995). Non-human primates are usually used as the second 
animal model.  
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Although there are various different animal models to study the pathogenesis of 
osteoporosis and for the preclinical testing of drugs, ovariectomized rats are considered 
as the primary and excellent animal model because it correctly emulates the clinical 
situation of estrogen depletion and the response of therapeutic agents in human skeleton 
(Jee and Yao 2001, Kimmel 1996, Yuehuei 1998). For instance, ovariectomy causes bone 
loss only in certain animals, such as rats and sheeps, but leads to unchanged bone mineral 
density (BMD) in dogs and other animals (Egermann et al. 2005). The studies on 
ovariectomized rat models showed that there is a biphasic loss of bone following 
ovariectomy. The initial rapid loss of bone takes place up to 100 days followed by an 
intermediate period of stabilization of cancellous bone volume at an osteopenic level 
(Egermann et al. 2005). The structural changes are more rapid in the initial phase of bone 
loss and it mimics the postmenopausal loss of cancellous bone (Egermann et al. 2005, 
Campbell et al. 2008).Studies show that the changes in the cancellous bone architecture 
are significant after two weeks (Campbell et al. 2008). These studies imply that 
postmenopausal osteoporosis can be better studied from the period of 2 to 12 weeks after 
ovariectomy when the bone loss is significant. Observations over 12 months post-
ovariectomy in rats revealed that the bone mineral content, bone area and body weight of 
ovariectomized rats are higher than that observed in humans (Egermann et al. 2005, 
Thompson et al. 1995). 
The selection of the most adequate animal model that is capable of reliable 
reproduction of the disorder is very important to study the disease. In the past, many 
researchers hold that the prevailing activity in rat skeleton is modeling, whereas it is both 
modeling and remodeling in human bone, and hence rodent models would not be 
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appropriate to study osteoporosis. However, rat model shows a gradual transition from 
modeling to remodeling that is related to progression of age in both cortical and 
trabecular bone (Dennison et al. 2005, Erben 1996). Another important factor to be 
considered while using rodent model is that rat bones retain their ability for longitudinal 
growth throughout most of their life. This mandates the use of a specific control group to 
differentiate the gain or loss of bone mass attributed to age and that caused by disease.  
One major disadvantage in using rat models of osteoporosis is the lack of 
Harversian system in the rat bones. Harversian remodeling is the main cause of cortical 
porosity in human bone. However, the similarity in the pathophysiological responses 
between the human and rat bone, combined with the husbandry and financial advantages, 
makes the rat a valuable animal model in osteoporotic and orthopedic research (Yuehuei 
1998, Lelovas et al. 2008). This thesis uses ovariectomized rats as the in vivo model to 
study the effect of estrogen levels on bone tissue and bone forming osteoblasts cells. 
2.1.4. Human fetal osteoblasts cell line 
A number of model systems utilizing osteoblasts cells to study the process of 
bone formation have been developed. Most widely used osteoblastic cells for the study of 
osteoblast biology and physiology include primary osteoblast cells derived from normal 
human (Robey and Termine 1985) and rat bones (Bakker and Klein-Nulend 2003, Owen 
and Pan 2008) and osteosarcoma cell lines derived from human (Liu et al. 2010, Rodan et 
al. 1987) and rats (Forrest et al. 1985, Schwartz et al. 1999). However, each of these cell 
lines has certain disadvantages. Osteoblastic cells derived from rats may show certain 
species specific phenotypic characteristics which differ from those of human osteoblasts 
cultures. The phenotypic similarity of untransformed osteosarcoma cells and their exact 
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nature of the genetic transformation event impose an uncertainty in using them for 
studying osteoblast biology. Primary cultures derived from human bone have the 
advantage to study the exact osteoblast phenotype and their characteristics, but they 
proliferate very slowly and become senescent after a short period in culture. Also, human 
primary culture is limited by the availability of bone samples from human subjects. 
To overcome these limitations Harris et al. (1995) developed immortalized human 
fetal ostoeblastic cell line (hFOB 1.19), which is presently the widely used in vitro model 
to study osteoblasts. hFOB 1.19 was established from biopsies obtained from 
spontaneous miscarriage. The primary cells isolated from the human fetal tissue were 
stably transfected with gene coding for temperature sensitive mutant of SV40 large T 
antigen, along with the neomycin resistance gene. The clone with highest alkaline 
phosphatase activity was screened for other phenotypic markers of osteoblasts and thus 
the hFOB 1.19 cell line was selected (Harris et al. 1995). This cell line is presently the 
widely used model to study normal osteoblast differentiation. Studies have shown that the 
hFOB cells are the easy available, homogeneous and consistent in vitro model to study 
the human mesenchymal progenitor cells (Yen et al. 2007). Therefore, hFOB 1.19 cell 
line was used in this thesis to study the in vitro direct effect of estrogen on osteoblasts 
cells. The direct effects of estrogen and selective estrogen-receptor modulators (SERMs) 
on hFOB cells had been characterized in terms of the cellular and molecular events of the 
cells (Noda-Seino et al. 2012, Miki et al. 2009, Tau et al. 1998). These studies suggest 
that hFOB cells are capable of eliciting a natural physiological response to the changes in 
the levels of estrogen and therefore they are suitable in vitro models to assess the effects 
of estrogen on osteoblastic cells. 
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2.2. Review on the current studies 
2.2.1. Ovariectomy induced changes of bone tissue and bone cells 
 The effects of in vivo estrogen loss due to ovariectomy on the tissue-level bone 
property and the efficacy of drugs to restore them had been rigorously studied. 
Ovariectomy in rats results in an increase in body weight of the rats (Campbell et al. 
2008, Yang et al. 2011, Yoon et al. 2012). Estrogen loss is known to cause rapid micro-
architectural deterioration of trabecular bone, which soon reaches a plateau (Campbell et 
al. 2008, Yoon et al. 2012, Yang et al. 2011). Using micro-CT, the changes in the 
trabecular micro-architecture were quantified in these studies as reduction in bone 
volume fraction (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th) and 
increase in trabecular separation (Tb.Sp) and trabecular porosity (Tb.Po). Reduction in 
bone mineral density (BMD) were observed as early as 4-8 weeks post-surgery (Yang et 
al. 2011, Yang et al. 2012, Lei et al. 2009) (Sheng et al. 2007, Lelovas et al. 2008, 
Egermann et al. 2005). Serum and urinary biomarker analysis showed an increased 
osteocalcin, c-terminal cross-linked telopeptides of type I collagen (CTX), 
deoxypyridinoline (DPD) indicating the increased bone remodeling (Shiraishi et al. 2009, 
Yoon et al. 2012, Campbell et al. 2008, Yang et al. 2011, Brennan et al. 2009). 
 Although the effects of ovariectomy on the bone quality of rat has been addressed 
extensively on the basis of changes in microarchitectural indices, densitometric and 
biomarker analysis, the nano-level intrinsic bone quality has seldom been studied. Earlier 
study on the intrinsic tissue modulus and hardness of vertebral trabecular bone of 
ovariectomized rat showed that even with significant loss in bone area fraction, the 
intrinsic tissue property remained unchanged (Guo and Goldstein 2000). However, a later 
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study on ovariectomized rats showed that there are changes in the intrinsic tissue property 
with respect to different sites (periosteal, central and endoesteal) of vertebral bone and 
that ovariectomy caused reduction in the cortical tissue hardness, modulus and dissipated 
energy (Hengsberger et al. 2005). A recent study showed that ovariectomy caused 
decreased cortical hardness and trabecular modulus, hardness and dissipated energy 
(Maïmoun et al. 2012). Thus, there are limited and contradictory information on the 
effects of ovariectomy on the intrinsic nanomechanical properties of the bone. In this 
thesis, we will be extensively studying the intrinsic tissue property changes of bone due 
to ovariectomy. This property would be more reflective of changes in the bone 
remodeling occurring at a nanoscale.  
 The in vivo effect of estrogen loss on osteoblasts properties had not been 
extensively studied. Osteoblasts derived from osteoporotic and normal human bones were 
observed to have different properties and varied response to 1,25(OH)2D3 (Torricelli et al. 
2002, Torricelli et al. 2003) and altered response to cyclic strain in terms of proliferation 
and transforming growth factor-β (TGF-β) expression (Neidlinger-Wilke et al. 1995). 
Osteoblasts from normal and osteoporotic patients also showed differences in the early 
cell adhesion events (Perinpanayagam et al. 2001). A recent study employing 
ovariectomized rat models showed that primary osteoblasts isolated from the mandible of 
ovariectomized and normal rats showed differences in cell ultrastructure, proliferation, 
differentiation, adenosine triphosphate (ATP) and reactive oxygen species (ROS) 
concentrations (Yu et al. 2012). In this thesis, mechanical, structural and functional 




2.2.2. Cellular and molecular effects of estrogen on osteoblasts, in vitro 
There are considerable evidences showing that estrogen directly regulates the 
proliferation and differentiation of osteoblasts. Both estrogen and testosterone prolong 
the lifespan of osteoblasts by inhibiting osteoblasts apoptosis (Syed and Khosla 2005, 
Kousteni et al. 2001). Thus, the deficiency of estrogen will result in accelerated 
osteoblasts apoptosis. Also, estrogen inhibits the cytokines (interleukin-I and tumor 
necrosis factor-α) which stimulates the apoptosis of the osteoblasts. The effect of 
estrogen on osteoblasts apoptosis is mediated through the activation of Src/Shc/ERK 
signaling pathway and down regulation of JNK (Kousteni et al. 2001). Estrogen is also 
known to stimulate the expression of type I collagen by osteoblasts. Thus, during 
estrogen deficiency, osteoblasts will have an impaired bone matrix  synthesis (Ireland et 
al. 2002, Ernst et al. 1988). 
Estrogen replacement was shown to prevent or delay the bone loss induced by 
postmenopausal osteoporosis. Despite all the clinical evidences of profound effect of sex 
steroids on bone metabolism, it was long believed that estrogen has indirect effect on 
bone since estrogen responsiveness in bone organ culture was not demonstrated. Those 
mechanisms were thought to decrease the bone resorption (Christiansen et al. 1982). But 
later, by omitting phenol red from culture media and using a primary rat calvarial 
osteoblasts cells, Ernst et al. (1989) proved that estrogen has a direct effect on 
osteoblasts. He found out that bone cells are sensitive to nanomolar concentrations of 
17β-estradiol. His findings were supported by the identification of low numbers of high-




Commercial estradiol is shown to increase proliferation of human osteoblasts in a 
concentration dependent manner between 1 nM and 8 nM reaching significance at a 
concentration of 8 nM (DiSilvio et al. 2006). A study on the comparative effects of 
estradiol and selective estradiol receptor modulators (SERMs) showed that both estradiol 
and SERMs increased the ratio of the cells in the S phase fraction of hFOB 1.19 cells. 
hFOB cells were sensitive to 10 nM to 1000 nM estradiol  which caused increased 
proliferation (Miki et al. 2009). A study on the effect of estradiol on the apoptosis of G-
292 human osteosarcoma cells showed that 10 nM of estradiol repressed the expression 
of apoptotic genes and inhibited caspase-3/7. This result suggests that estradiol is capable 
of preventing the apoptosis of osteoblasts (Bradford et al. 2010). On contrast, studies on 
the direct effect of estradiol on the rat osteosarcoma cells (UMR106) showed that 
estradiol decreases the growth rate of the osteosarcoma cells. 10 nM estradiol is shown to 
increase the alkaline phosphatase activity of osteoblasts (Gray et al. 1987).  
Thus, estradiol is shown to have a direct effect on osteoblasts cells in vitro. These 
effects are documented in terms of proliferation assays, alkaline phosphatase activity, 
gene expression at mRNA and protein levels etc. The direct effects of estrogen on the 
mechanical property of osteoblasts had not been addressed before. This thesis is the first 
ever study to analyze the direct effect of estradiol on the mechanical properties of hFOB 
1.19 cell line and hence the changes in the underlying cytoskeletal. We believe that this 
study would provide insight into the mechanistic changes in the bone forming 





2.2.3. Mechanical properties and mechanotransduction of osteoblasts  
As previously mentioned in section 1.5, bone cells respond to dynamic stresses. 
When a compact bone is subjected to mechanical stress, the interstitial fluid in the bone 
matrix flows away from the regions of high compressive stress. The magnitude of 
interstitial fluid flow is related to the magnitude of the exerted force. This stress 
generated potentials is hypothesized to stimulate the bone cells to initiate bone 
remodeling. Increased mechanical loads are shown to increase the fluid flow through the 
lacuna-canalicular networks (Knothe Tate et al. 2000). It is widely believed that this flow 
acts as the mechanical stimulus on osteocytes (Weinbaum et al. 2001, Weinbaum et al. 
1994). The osteoblasts were also shown to respond to fluid shear stress by synthesizing 
more cAMPs (Reich et al. 1990). Compared with osteoblasts and its progenitors, 
osteocytes were more responsive to fluid shear stress in vitro (Westbroek et al. 2000). It 
is believed that during the course of differentiation from immature osteoblasts to 
osteoblasts to osteocytes, the sensitivity to fluid shear also increases. Thus, it is 
hypothesized that mechanotransduction of osteocytes and partially by osteoblasts signals 
and recruits osteoclasts and osteoblasts for bone remodeling (Mullender et al. 2004). 
Mechanical strains, as low as 7 pN, were shown to activate the calcium channels in 
osteoblasts, resulting in cell proliferation, synthesis of active regulatory molecules, 
changes in protein mRNA expression, matrix synthesis, cell alignment and enzyme 
release. Stretch-sensitive ion channels or the integrin-cytoskeletal interaction was 
believed to play a role in the mechanotransduction of osteoblasts (Mullender et al. 2004). 
On the other hand, the differentiation of human mesenchymal stem cells to osteoblasts is 
also shown to be induced by fluid shear stress (Liu et al. 2010). 
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The most studied mechanosensors in osteoblasts are the mechanosensitive 
calcium channels and the integrins. Other elements that are involved in mechanosensing 
are the cell-cell adhesion elements such as cadherins and gap junctions, cytoskeleton 
constituents, the ECM constituents and focal adhesions (Papachroni et al. 2009). Upon 
mechanosensing, osteoblasts respond to the mechanical force by activation of MAPKs, 
Cox-2, NO, TNF-α and Wnt-β-catenin, secretion of growth factors, which are not specific 
for cells of osteoblasts lineage but are local regulators of osteogenesis. Moreover, the 
effect of growth factors to synthesize nuclear proteins is mediated by sex steroids, 
growth hormones and glucocorticoids (Papachroni et al. 2009). Thus, studying the 
mechanical properties of these mechanosensitive cells during estrogen deficiency is 
expected to give insights to the pathogenesis of postmenopausal osteoporosis.  
The elastic modulus of osteoblasts as measured by AFM was observed to vary 
with the substrate. The ECM and the nature of adhesion of osteoblasts to the substrate 
determine the elastic modulus of the cell (Domke et al. 2000, Takai et al. 2005). Also, 
cells seemed to be well spread with fibronectin coated substrate than the glass. Thus, the 
adhesion of the cells to the substrate determines the cytoskeletal structure and hence the 
elastic modulus (Takai et al. 2005). Primary osteoblasts isolated from long bones of 
neonatal rats are shown to respond to mechanical stimulation by indentation using AFM. 
Intracellular calcium concentration of the osteoblasts was found to increase following 
indentation. Also, cell thickness was shown to influence the order of magnitude of the 
cellular strains (Jaasma et al. 2007). MC3T3-E1 osteoblasts cells subjected to fluid shear 
were shown to have increased whole cell stiffness, measured by AFM. This increase in 
stiffness remained for 70 minutes after the flow was terminated. Flow-induced 
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rearrangement of actin cytoskeleton also remained for at least 90 minutes after the flow 
was terminated. These studies show that the cells become mechanically adapted by the 
rearrangement of cytoskeleton. Cellular mechanical adaptation can play an important role 
in regulating mechanosensitivity and hence the tissue structure and function (Jaasma et 
al. 2006). The elastic modulus of osteoblasts measured by AFM ranges between 0.3 to 20 
kPa, depending on the state of cell adhesion and approach used to measure the elastic 
modulus (Simon et al. 2003). AFM is also being used to image the cytoskeletal structures 
and the whole cell structure (Domke et al. 2000, Simon et al. 2003). Thus, AFM had been 
used to study the mechanosensitivity as well as to measure the elastic modulus of the 
osteoblasts and also to image the cellular structures of osteoblasts.  
In this thesis, we will be studying the direct effects of estrogen on both the 











IN VITRO: EFFECT OF ESTRADIOL 
ON OSTEOBLAST MECHANICAL 






As seen from the previous chapters, mechanical properties of the biological cells 
could play an important role in the physiological functions. Bone cells are particularly 
interesting as they are able to sense the mechanical signals and respond to it with changes 
in bone remodeling. Bone-forming osteoblastic cells were known to be directly 
influenced by estrogen. In this chapter, the effect of estradiol (commercially available 
estrogen) on mechanical and structural properties of the osteoblasts was studied. This is 
the first study to focus on the mechanical property changes of osteoblasts with respect to 
the levels of estrogen.  
3.1. Introduction 
Estrogen deficiency is known to trigger an increase in bone remodeling, which is 
characterized by increased osteoclastic activity (bone resorption), and increased but 
relatively deficit osteoblastic activity (bone formation). This causes rapid loss of bone 
mass and microarchitecture, resulting in osteoporosis (Lerner 2006, Syed and Khosla 
2005, Yang et al. 2011). Estrogen and selective estrogen receptor modulators (SERMs) 
have been shown to be effective in preventing bone loss in postmenopausal osteoporosis 
(Barzel 1988, Fontana and Delmas 2003). Both in vivo and in vitro studies showed that 
estrogen increases osteoclasts apoptosis and decreases osteoclastic activity thereby 
decreasing bone resorption (Oursler et al. 1991, Novack 2007, Turner et al. 2008). In vivo 
studies showed that estrogen deficiency post-ovariectomy in animals resulted in an 
increase in osteoblasts-lined perimeter in long bones of rats and also an increased bone 
formation rate by osteoblasts (Turner et al. 2008, Wronski et al. 1986).  
The effect of estrogen on osteoblasts in vitro has been extensively studied. The 
presence of estrogen receptors (ER) in osteoblasts and osteoblasts-like osteosarcoma cells 
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indicates that estrogen can have a direct effect on these cells (Eriksen et al. 1988, Miki et 
al. 2009, Gray et al. 1987). Different studies showed contradicting results that estrogen 
stimulates, inhibits or has no effect on proliferation, alkaline phosphatase activity and 
osteocalcin expression of osteoblasts (Turner et al. 2008, Miki et al. 2009, Gray et al. 
1987, Robinson et al. 2000, Ernst et al. 1989). Estrogen stimulates gene expression 
associated with type I collagen and osteoprotegrin (Turner et al. 2008, Ernst et al. 1989). 
There are also evidences suggesting an inhibitory effect of estrogen on osteoblasts 
apoptosis (Turner et al. 2008, Bradford et al. 2010). Overall, osteoblasts are known to be 
directly influenced by estrogen at the cellular and molecular level that in turn influences 
the physiological functions of the cells.  
Studies on single cell mechanics are gaining importance in understanding the 
difference between diseased state cells and healthy ones. Progression of disease states 
such as malaria, cancer is strongly associated with changes in mechanical properties of 
the concerned cells (RBCs and tumor cells) (Lim et al. 2006, Li et al. 2008). Bone cells 
are particularly interesting for studying single cell mechanics because bone tissue is 
known to respond continually to the externally applied mechanical forces by adapting its 
shape and architecture (Morgan et al. 2008, Lee et al. 2002, Garner et al. 2000). The bone 
elements are known to place or displace themselves in the direction of functional stresses 
and increase or decrease their mass to reflect the amount of the functional forces (Morgan 
et al. 2008, Wolff 1986). Thus, bone is known to respond to intermittent mechanical 
loads through changes in bone remodeling (Wolff 1986, Chamay and Tschantz 1972). At 
cellular level, there are evidences showing that osteocytes and osteoblasts act as 
mechanosensors of bone and respond to mechanical forces through functional changes 
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and altered bone remodeling (Westbroek et al. 2000, Vezeridis et al. 2006, Ban et al. 
2011, McGarry et al. 2008). The mechanical integrity of the osteoblasts cells can be 
crucial to its mechanosensory function.  
Whether estrogen has an effect on the stiffness of the osteoblasts that can 
potentially affect its function, has still not been studied. This is the first study aimed to 
investigate the changes in the apparent elastic modulus (E*) of the human fetal 
osteoblasts cell line following treatment with β-estradiol using Atomic Force Microscopy 
(AFM).  Invented in 1986 by Binning et al, AFM soon became a valuable and useful tool 
for imaging and as a force sensor with piconewton force resolution, thus making it a 
potential tool to study single cell mechanics (Binning and Quate 1986). AFM is widely 
used to probe the micromechanical properties of soft living cells in their physiological 
environment (Lim et al. 2006, Li et al. 2008, Kuznetsova et al. 2007, Zhang et al. 2008, 
Jaasma et al. 2006). This study aims to analyze the structure-mechanical property-
function relationship of osteoblasts cells with reference to estradiol treatment. E* of the 
osteoblasts was quantified and compared to corresponding changes in F-actin cytoskeletal 




3.2. Materials and Methods 
Cell culture 
The human fetal osteoblasts cell line, hFOB 1.19, was bought from ATCC (CRL-
11372). The cells were cultured in a 1:1 mixture of Ham’s F12 medium and Dulbecco’s 
Modified Eagle’s Medium without phenol red (Invitrogen), supplemented with 0.3 mg/ml 
G418 (Sigma Aldrich) and fetal bovine serum (HyClone sera, Thermo scientific)  to a 
final concentration of 10%. The cells were maintained in a 5% carbon dioxide incubator 
(Sanyo) at 34oC. After the cells become 90% confluent, the cells were trypsinated. 2x104 
cells were seeded on sterile 13 mm cover slips (Heinz glass), kept in a 24 well tissue 
culture plate (Greiner bio-one) and grown in the complete culture medium in the carbon-
dioxide incubator. After the cells reached confluency, the cells were grown with complete 
growth media only (Control group) or complete growth media supplemented with 10 nM 
or 100 nM of β-estradiol (Sigma Aldrich). After two days of incubation in the carbon-
dioxide incubator, corresponding medium was replaced to remove any dead cells on the 
cover slip. On the subsequent day, the cells were subjected to AFM indentation test and 
confocal imaging with phalloidin staining. The cells were prepared in similar conditions 
and subjected to mineralization assay, alkaline phosphatase assay and MTT cell 
proliferation assay. 
Atomic Force Microscopy 
A nanoscope IV multimode AFM with a picoforce scanner (Digital Instruments 
Inc, USA) was used to image the cell and conduct force indentation experiments to 
determine E*. The osteoblasts, grown on the 13 mm glass cover slip and mounted on a 
mica glass, served as the sample for analysis. This sample was mounted on the AFM 
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stage and kept immersed in phosphate buffered saline (PBS) using a fluid cell (Digital 
Instruments Inc, USA), throughout the experiment. An optical microscopy system 
attached with the AFM was used to view the cells and the position of the tip.  
Imaging: For imaging, 70% confluent culture of hFOB cells over the glass cover slip was 
used as sample. A sharp silicon tip with a low spring constant and high sensitivity silicon 
nitride cantilever was used. The tip was placed on the center of the cell and raster 
scanned over an area of 50 µm x 50 µm, in contact mode. The V613r1 version of the 
nanoscope software (Digital Instruments Inc) was used to analyze the image generated, 
by creating a histogram data of height of all the image pixels and determining the 
maximum height of the sample as shown in Figure 5.1. 
 
 
Figure 3.1: Determination of height of the cells by AFM (A) Image of the cell 
generated by AFM. (B) Histogram showing the height distribution of the image. The 
peak height was found to be 3.5 µm for this image 
 





For force indentation experiments with AFM, the confluent cells grown on the 
cover slips (with and without estradiol treatment) were used. For measuring the whole 
cell mechanical property, instead of the conventional sharp tip, a modified silicon nitride 
AFM cantilever of spring constant 0.03 N/m with a spherical polystyrene bead of 
diameter 4.5 µm adhered to the tip (NovaScan technologies) was used for AFM 
indentation. Force indentations with spherical bead indenters offers many advantages 
such as assessment of the elastic modulus of the cell by averaging over a larger surface 
area of contact and reduced local strains on the contact surface during indentation that 
reduces the non-linear or destructive deformation of the cell (Li et al. 2008). From a 
single indentation of the spherical bead indenter onto the cells, the force displacement 
curve is traced using AFM. This curve contains the information about the force 
interaction between the tip and the sample surface as a function of relative tip-sample 
distance during the indentation of tip on the cell surface. Sneddon’s mechanics was 
employed to determine the E*. First, a force curve was recorded by indenting the tip on 
the substrate as reference. Later, another force curve was generated by indenting the cells. 
The difference between these two deflections is a measure of the indentation depth of the 
probe into the cell (h). E* of the sample can be determined from the force (F) versus 
indentation (h) curve using equation 5.1. From Hertzian contact law, the force can be 
related to the indentation as,                                                     
      * 3/24
3
RF h E h                          (5.1) 
where, R is the radius of the spherical bead (2.25 µm), used to indent the sample. From 




Staining for actin cytoskeleton 
For staining of actin cytoskeleton, the cells were prepared on 13 mm coverslips in 
the same way as prepared for AFM indentation studies. The cells were first washed with 
PBS and fixed using 4% paraformaldehyde (PFA, Sigma Aldrich) for 15 minutes. The 
cells were then permeabilized by treating with 0.2% Triton-X 100 (Promega pte ltd, 
USA) for 10 minutes. The F-actin filaments were stained by incubating with 0.1 µg/ml 
TRITC-Phalloidin (Sigma Aldrich) for 45 minutes in dark. The stained cells on the 13 
mm coverslips were mounted on a 22 mm x 60 mm VFM coverslip (CellPath) using 
mounting medium (Olympus). The images were taken using Olympus FV500 confocal 
imaging system in a water immersion lens at 60X magnification. 
Mineralization assay 
Mineralization of the osteoblasts was assessed qualitatively by Von Kossa 
staining (Harris et al. 1995). The cells were fixed with 4% PFA (Sigma Aldrich). After 
washing with distilled water, the fixed cells were incubated with 1% silver nitrate (Sigma 
Aldrich) under ultraviolet light for 45 minutes. The cells were further washed with 
distilled water and treated with 3% sodium thiosulfate (Sigma Aldrich) for 5 minutes to 
remove unreacted silver. After washing with distilled water, images were taken using 
Olympus IX-71 inverted optical microscope. Mineralization was quantitatively assessed 
using OsteoImage™ mineralization assay kit (Lonza Walkersville, Inc.). The OsteoImage 
assay is based on specific binding of the fluorescent staining agent to the hydroxyapatite 
portion of the mineralized nodules. The fluorescence intensity was measured at 492 nm/ 
520 nm using a microplate reader (FLUOstar OPTIMA, BMG Labtech). 
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Alkaline Phosphatase activity  
The alkaline phosphatase activity of the confluent cells was analyzed using the 
alkaline phosphatase reagent (Alkaline Phosphatase Yellow (pNPP) Liquid Substrate 
System for ELISA, Sigma Aldrich). After 30 minutes of incubation with the reagent at 34 
oC in the carbon-dioxide incubator to yield a yellow enzymatic reaction product, 50 µl of 
3N NaOH was added to stop the reaction. Absorbance was measured at 405 nm using the 
microplate reader.  
MTT assay 
For MTT assay, the confluent cell culture in a 96-well plate was grown in 
medium alone and medium supplemented with 10 nM and 100 nM estradiol for 3 days. 
MTT assay was carried out by adding 10 µl of 5 mg/ml of 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide solution to each well. After 4 hours of incubation at 34 
oC in the carbon-dioxide incubator, the medium was removed and 100 µl of DMSO was 
added to each well. The absorbance was then measured at 570 nm using the microplate 
reader.  
Statistical Analysis 
 All results are expressed as mean±SEM (Standard Error of Mean) for all the 
experiments. All data were analyzed by two tailed student t-test assuming unequal 




Preliminary tests for AFM 
Initially, the AFM test condition needs to be optimized for every cell kind. To 
probe the elastic property of the cell, it is important to note that the indentation depth of 
the probe into the sample is less than 10% of the height of the sample, so that there is no 
substrate influence on the measured elastic modulus. The cell samples were first imaged 
using AFM to determine the height of the cells. A total of 10 cell images were generated 
using AFM and the measured heights of the cells are given in Table 3.1.  
 
Table 3.1. The height of 10 samples of hFOB cells imaged using AFM 
 















It can be observed that the height of the samples vary from 3 to 10 µm. This 
difference in cell height may be due to the fact that, the cells in culture will be in different 
phase of growth and accordingly the height and size of the cell would vary. Considering 
the smallest height of the cell in culture (3 µm), it was assumed that the indentation depth 
for AFM force indentation experiments should not exceed 0.3 µm to overcome surface 
interferences. Following height measurement, AFM force indentation was carried out on 
hFOB cells at scan rates of 0.1 and 0.5 Hz and trigger threshold of 200 and 500 pN. For 
these parameters the measured average indentation depth and elastic modulus of the cells 




Figure 3.2. Indentation depth for different scan rates and trigger threshold, n=21. Error 




Figure 3.3. Apparent elastic modulus for different scan rates and trigger threshold, n=21. 
Error bar indicates standard deviation. 
 
 
The indentation depth increased with increased trigger threshold and decreased 
with increased scan rate. The student t-test revealed statistical significance for all 
comparisons. A trigger threshold of 500 pN cannot be used for force indentation 
experiments as the indentation depth exceeded 0.3 µm. A scan rate of 0.1 Hz was chosen 
for experiments as the elastic property of the cells could be best studied by slower 
indentation rates. Accordingly, it was observed that 0.5 Hz scan rate produced larger 
standard deviation in measurement of elastic modulus, as compared 0.1 Hz scan rate. 
Thus, for subsequent force indentation experiments, the cells were indented in its center 
at an indentation force threshold of 200 pN and at the rate of 0.1 Hz to ensure minimal 
indentation depth on cell surface that reduces substrate contributions (Li et al. 2008, 





Apparent elastic modulus of the cells 
The force (F) versus indentation depth (h) curves of control and estradiol treated 
cells are shown in Figure 3.4. These curves qualitatively show that for the same force 
applied, the indentation depth was higher in estradiol treated cells as compared to the 
control group. This suggests that the resistance to deform against the mechanical load has 
reduced in the estradiol treated cells. Thus, control group cells are stiffer than the 
estradiol treated cells. 
    
 
Figure 3.4. Indentation force versus indentation depth curve of control, 10 nM and 100 






For total indentations on 25 cells per group, the calculated average apparent 
elastic modulus of the three groups is represented in Figure 3.5. The control group cells 
(E* = 0.578±0.093 kPa) had significantly higher apparent elastic modulus than the 10 nM 
and 100 nM estradiol treated groups (E* = 0.332±0.040 kPa, p=0.021 and 0.315±0.035 
kPa, p=0.013 for 10 nM and 100 nM estradiol, respectively). There was no significant 
difference between cells treated with 10 nM and 100 nM estradiol (p = 0.744).  Thus, the 
E* of 10 nM and 100 nM estradiol treated hFOB cells was significantly lesser than the 




Figure 3.5. Averaged apparent elastic modulus of control and estradiol treated hFOB 
cells (n=25 for each group). Error bar indicates standard error of mean. * indicates 
















Actin cytoskeletal structure 
According to the tensegrity model, the filaments of actin cytoskeleton form a pre-
stressed mechanical network that determines the structure and stiffness of the cell 
(Houben et al. 2007). Thus, further investigation on the actin structures is crucial to 
understand the underlying reason for the changes in the elasticity of osteoblasts. Confocal 
images of TRITC-Phalloidin stained cells (Figure 3.6) showed that the actin filaments 
were denser in the control group cells as compared to the estradiol treated cells. The 
estradiol induced decrease in the density of actin filaments of osteoblasts cells can lead to 
decreased stiffness of the cells.  
 
Figure 3.6. Confocal images of the TRITC-phalloidin stained control cells and 10 nM 




Mineralized matrix of osteoblasts 
The presence of mineralization was qualitatively assessed in both the control and 
estradiol treated cells by Von Kossa staining. Black hydroxyapatite crystals were sparsely 
found in both estradiol and control group cells (Figure 3.7).  
 





Figure 3.7. Von Kossa staining of cells 3 days post-confluency showing the presence of 
mineralized deposits in all group cells. 
 
 
The quantified mineralization of all groups using OsteoImage mineralization 
assay are represented in Figure 3.8. OsteoImage assay revealed that there was very low 
mineralization in both the control and estradiol treated hFOB cells, with no significant 
difference between different groups (p > 0.6 for all comparisons). 
 
Figure 3.8. Osteoimage quantification assay of mineralization of control and 10 nM and 





























 The mineralization ability of hFOB cells with treatment of 10 nM estradiol was 
also assessed 14 days post-confluency. After the cells reached confluency, the cells were 
grown in medium alone and medium with 10 nM estradiol. The medium was regularly 
changed once in 3 days until 14 days. As shown in Figure 3.9, mineralized nodules were 
visible through Von Kossa assay in both control and estradiol treated cells. Thick 
mineralized nodules were observed in control cells that are sparsely placed. In estadiol 
treated cells, the formation of thick nodules seems to be inhibited. Smaller mineralization 
nodules were closely placed throughout the culture surface in estradiol treated cells.  
 
Figure 3.9. Von Kossa staining of control and estradiol treated cells 14 days post-
confluency. 
 
Alkaline phosphatase activity and proliferation 
Figure 3.10 represents the alkaline phosphatase activity of the cells from all three 
groups. The percentage increase in the alkaline phosphatase activity of 10 nM and 100 
nM estradiol treated cells as compared to the control group cells was 41% (p=0.017) and 
37% (p=0.039) respectively. There was no significant difference between the alkaline 





Figure 3.10. The percentage increase in the alkaline phosphatase activity of 10 nM and 
100 nM estradiol treated cells as compared to the control group cells (n=3). * indicates 
p<0.05 as compared to control group.  
 
 
The changes in alkaline phosphatase activity can also be caused by difference in 
the total number of cells of each group for which alkaline phosphatase activity is 
measured. Thus MTT assay was used to assess the difference in cell number or cell 
proliferation rate between the control and estradiol treated cells. Since the objective is to 
assess the cell number in the same experimental condition as other tests, MTT assay was 
carried out on 100% confluents cells. The results are given in Figure 3.11. It was 
observed that there was no significant difference in the cell proliferation of different 
group cells (p > 0.3 for all comparisons). Thus, the increase in the alkaline phosphatase 
enzyme activity was not caused by increased number of cells, but due to increased 

















































A number of model systems have been widely used to study osteoblast biology, 
which include primary osteoblasts derived from normal human and rat bones and 
osteosarcoma cell lines derived from tumors. Most model systems have their own 
limitations to use for studying osteoblasts, such as the differences in genetic response of 
osteosarcoma cells as opposed to osteoblasts cells, species specific characteristics of rat 
osteoblasts culture, limitation in availability of human explants and relatively slower 
growth rate of primary human osteoblasts (Harris et al. 1995).  Studies have shown that 
the hFOB 1.19 cell line is easily available, homogeneous and consistent in vitro model to 
study the human mesenchymal progenitor cells (Yen et al. 2007). A nominal expression 
of estrogen receptor β (ERβ) and a weak expression of estrogen receptor α (ERα) have 
been reported on the hFOB commercial cell line (Miki et al. 2009, Waters et al. 2001). 
Similarly, the osteoblasts located on human cancellous bone are known to express ERβ 
predominantly and not ERα (Miki et al. 2009, Turner et al. 2008). On contrary, the 
osteoblasts-like osteosarcoma cells are known to express higher levels of ERα than ERβ 
(Miki et al. 2007). The hFOB cells, therefore, are expected to maintain native regulatory 
pathways on direct treatment of estradiol as that of the human trabecular lining 
osteoblasts.  
In this study, we analyzed the changes in mechanical properties of osteoblasts on 
treatment with estradiol on 100% confluent culture. This is because the elastic modulus 
of the osteoblasts cells is known to differ widely for cells at different phases of cell cycle 
(Kelly et al. 2011). Thus it is important to synchronize the cells to particular phase of cell 
cycle in order to have a valid comparison between different groups. When the cells 
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become fully confluent, the contact inhibition prevents further growth and proliferation of 
cells, thereby synchronizing the cells to G0 phase of cell cycle (Davis et al. 2001). This 
G0 quiescence is also similar to cell phase of the resting trabecular lining osteoblasts 
cells.  
The optimal dose of β-estradiol to elicit a proper genetic and physiological 
response on human osteoblasts is generally 10 nM for in vitro studies (Miki et al. 2009, 
Gray et al. 1987, Ernst et al. 1989). In our study, the results of 10 nM estradiol treated 
cells can be considered as the pharmacological effects of β-estradiol on human 
osteoblasts in vitro. The results of 100 nM estradiol on hFOB cells were obtained to 
represent any positive or negative changes induced by higher concentrations of estradiol 
on osteoblasts. Overall, our study represents the effect of pharmacologically optimal dose 
and a higher concentration of estradiol on the mechanical property of osteoblasts cells, 
similar to the trabecular bone lining osteoblasts cells. 
In this study, estradiol induced reduction in the stiffness of the osteoblasts was 
substantiated, which was caused by decrease in the density of F-actin filaments. This is in 
accordance with a previous study, which showed that elastic modulus of the cells at the 
regions containing F-actin filaments were higher than those regions that lack those 
structures (Costa et al. 2006). Bone is known to respond to mechanical stresses by 
alteration in bone remodeling (Morgan et al. 2008, Wolff 1986, Chamay and Tschantz 
1972). Being the bone lining cells, osteoblasts are often exposed to different kinds of 
mechanical stresses in vivo, such as the fluid shear stress, hydrostatic pressure and 
stretching stress. Osteoblasts’ response to these kinds of mechanical forces could be 
pivotal to their physiological functions. MC3T3-E1, hFOB and primary osteoblastic cells 
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are known to respond to fluid shear stress through increased whole cell stiffness and fluid 
shear induced aggregation of cytoskeleton (Jackson et al. 2008, Liu et al. 2010, Jaasma et 
al. 2007). MC3T3-E1 osteoblasts are known to respond to indentation forces through 
nitric oxide mechanotransduction that involves cytoskeleton (McGarry et al. 2008). These 
studies indicate that during the process of mechanotransduction, osteoblasts cells get 
mechanically adapted by rearrangement of cytoskeleton and altered cell stiffness. 
Cellular mechanical adaptation through cytoskeletal rearrangement of osteoblasts can 
play an important role in regulating bone remodeling and hence the bone form and 
function. In our study, estradiol treated cells are shown to have less dense F-actin 
filaments, which results in relatively easily deformable osteoblasts. We quantified the 
stiffness decrease in osteoblasts cells to be 43% – 46%. Given the role of cytoskeleton 
and stiffness of osteoblasts in its mechanotransduction, osteoblasts with different stiffness 
and cytoskeletal composition, can respond to mechanical stress in different way or 
different rate. Thus mechanosensory function of osteoblasts is speculated to be influenced 
by estrogen. Eventually it is possible that during the pathogenesis of postmenopausal 
osteoporosis, estrogen deficiency induced mechanical changes of bone-lining osteoblasts 
cells can become vital to its mechanosensory function and downstream effects.  
The elastic modulus of osteoblasts measured by AFM is known to be substrate 
dependent (Takai et al. 2005).  The extracellular matrix modulates the arrangement of F-
actin thereby influencing the measured elastic modulus of the cell. Osteoblasts are known 
to synthesize the mineralized matrix in vivo. In vitro osteoblasts culture also deposits 
similar matrix on induction with L-ascorbic acid and β-glycerophosphate. However, post-
confluent hFOB culture was known to deposit mineralized matrix without induction 
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(Harris et al. 1995). Since we use post-confluent hFOB cells for our study, it is important 
to analyze the mineralization to study any contribution of the mineralized matrix to the 
measured E*. We found that at the time point of our study (3 days treatment of estradiol 
post-confluency), mineralization is very sparse without any significant difference 
between different groups, thus confirming that the changes in E* was not associated with 
changes in the mineralized matrix of the cells. However, 14 days post-confluency, the 
effect of estradiol on the mineralized nodule formation of hFOB cells was well 
pronounced. Estradiol was found to inhibit the thicker mineralized nodule formation. 
This is in agreement with a previous study which showed estrogen inhibits the 
mineralized nodule formation in vitro, which is prominent after 11 days of treatment with 
estrogen (Waters et al. 2001). This influence of estrogen on the nodule formation depends 
on the ERα isoform of the hFOB cells. In our study, it was found that estradiol actually 
causes smaller mineralization nodules that are uniformly present all through the surface, 
whereas the control group has sparsely placed thicker nodules. This direct effect of 
estrogen on mineralization can be crucial at tissue level for the mechanical integrity of 
bone. 
Alkaline phosphatase activity is the most widely used biochemical marker for 
osteoblasts activity. Higher alkaline phosphatase activity of the osteoblasts would 
indicate an enhanced differentiation of cells in vitro (Gray et al. 1987). A decrease in 
osteoblasts elasticity following estradiol treatment was also associated with an increase in 
the alkaline phosphatase activity of the cells. This increase was not caused by increased 
osteoblasts cell number, as the MTT assay revealed that there was no apparent change in 
the osteoblasts cell number or proliferation during the time of our study. MTT assay was 
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conducted on 100% confluent cells in order to assess the cell proliferation activity at 
similar experimental conditions as other experiments. The presence of contact inhibition 
in the confluent cell culture could prevent further proliferation of the cells resulting in 
similar proliferation activity for all group cells. Overall, it was observed that estradiol 
increases the inherent alkaline phosphatase activity of the individual cell and hence the 
cell differentiation rate. Thus estradiol causes increased differentiation of osteoblasts 
along with altered stiffness of the cells. It was also observed in our study that 100 nM 
estradiol elicited similar kind of responses as 10 nM estradiol, in all the studied 





The major conclusions of the study are summarized as follows. 
 β-estradiol causes the hFOB cells to become less stiff by reducing the density of F-
actin network. This change in the elasticity of osteoblasts can possibly influence the 
mechanotransduction of the cells, further affecting the mechanical integrity of the 
bone.  
 There was also a marked increase in inherent alkaline phosphatase activity of the cells 
following estradiol treatment of the cells.  
 The changes in the elasticity of the cells were not caused by changes in the 
synthesized mineralized matrix of the cell.  
 There can be estradiol induced changes in mineralization ability of osteoblasts cells at 











IN VIVO: ALTERATIONS OF BONE 
















In the previous chapter, the direct effects of estradiol on the mechanical and 
structural properties of osteoblasts were studied. Estradiol was found to decrease the 
stiffness of the cells through cytoskeletal modification. Following that, we proposed to 
study influence of in vivo conditions on osteoblasts mechanical property. Ovariectomized 
rat models were used for the purpose. The effects of ovariectomy on tissue level 
properties of long bones were initially studied before focusing on the cellular level 
changes. In this chapter, the effects of ovariectomy on bone tissue properties were 
extensively studied in terms of micro-architectural, densitometric, geometric, mechanical, 
viscoelastic and intrinsic tissue properties.   
4.1. Introduction 
The most commonly used animal model for studying postmenopausal 
osteoporosis research is the ovariectomized rat, wherein, removal of ovary causes a 
deficiency in levels of estrogen triggering bone deterioration, similar to the 
postmenopausal bone loss. Osteoporotic fracture risk is most often assessed by the 
clinical index, BMD, measured using dual-emission X-ray absorptiometry (DXA). The 
measured apparent density, represented as T-score, is used to predict osteoporosis. 
However, in addition to BMD, bone strength is also determined by factors such as 
trabecular and cortical micro-architecture, bone geometry, accumulation of 
microdamages and intrinsic material property of the tissue (Maïmoun et al. 2012, 
Hengsberger et al. 2005, McCreadie and Goldstein 2000). Given the complex hierarchical 
structure of bone, there are other crucial determinants of bone strength which may or may 
not correlate with the BMD (Ammann et al. 2007, Hofmann et al. 1997, McNally and 
Borgens 2004, Miller et al. 2007). These parameters can be employed in experimental 
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analysis to evaluate the extent of bone deterioration due to osteoporosis, so as to 
understand the complex mechanism of pathogenesis of osteoporosis. Together with 
BMD, these parameters would serve for a more accurate determination of various 
changes in osteoporotic bone quality and hence the drug efficacy.  
The complicated mechanical properties of bone tissue arise from its complex 
hierarchical structure with its different components undergoing dynamic remodeling. 
(Hoh and Schoenenberger 1994, Pesen and Hoh 2005). The complex hierarchical 
structure of bone includes macro scale cortex - trabeculae, micro scale osteon - lamellae 
and nano scale collagen fibers - hydroxyapatite crystals (Chang et al. 2011). The 
composite structure of bone consisting of collagen as biopolymer and hydroxyapatite 
crystals as mineral gives rise to the viscoelastic property of the bone. Bone viscoelastic 
property arises from the void collapse, densification of trabeculae and the natural 
viscoelastic response of collagen fiber as a polymer (Schwartz et al. 1999, Brennan et al. 
2009, Ammann et al. 2007). Loss tangent of cortical bone, which is a viscoelastic 
parameter, have been demonstrated as an effective tool to test human bone strength 
(Moloney et al. 2004). Les et al. (2005) also demonstrated that long-term ovariectomy 
decreases ovine compact bone viscoelasticity. These studies revealed a possibility that the 
development of osteoporosis is associated with the deterioration in viscoelastic property 
of bone. A study on ovariectomy-induced changes in viscoelastic property of bone would 
help us better understand the pathogenesis of osteoporosis. Nanoindentation has been 
employed in recent years to determine the nanomechanical properties of mineralized 
tissues, providing material properties of individual constituents of bone at a resolution of 
1 m (Lewis and Nyman 2008, Brennan et al. 2009). A recent study indicates that lower 
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creep viscosity, as measured by nanoindentation can play an important role in long term 
degradation of mechanical stability of the bone (Bushell et al. 1999).   
The main objective of this study was to extensively look at different factors of 
bone quality during the pathogenesis of osteoporosis, as induced by estrogen deficiency. 
Ovariectomy-induced changes at the metaphysis of long bones were studied in terms of 
trabecular micro-architectural parameters as measured by microCT, densitometric and 
geometric parameters as measured by pQCT, mechanical parameters as measured by 





4.2. Materials and Methods 
Animal work 
Twenty-eight female Sprague Dawley rats (Laboratory Animal Centre, National 
University of Singapore) of age 3 months were housed at 25 oC under a 12:12-hour light-
dark cycle and fed standard rodent diet (Harland, Model T.2018S) and water ad libitum. 
The rats were divided into 2 groups namely, OVX (n=12) and SHAM (n=16) and 
subjected to bilateral ovariectomy and sham surgery, respectively. All animal 
experiments were conducted in accordance with the approved protocol from the 
Institutional Animal Care and Use Committee (IACUC) at the University.  
Bilateral ovariectomy refers to the surgical removal of both the ovary. 2% v/v 
Isofluorane is circulated through the nose cone to keep the animal anaesthetized during 
the protocol. The abdomen is shaved and cleaned with 3 alternating swabs of any two 
sterilants (povidone-iodine & 70% alcohol).  Under aseptic conditions, a dorsal midline 
skin incision was made caudal to the posterior border of the ribs. Using blunt dissection 
to tunnel subcutaneously, lateral to the skin incision, the muscle layer of the posterior 
abdominal wall was incised to enter the abdominal cavity. Using forceps, the periovarian 
fat is gently grasped to lift and exteriorize the ovary (Figure 4.1). Mosquito forceps were 
used to crush the fallopian tube and cranial-most part of the uterine horn distal to the 
ovary. The ovary was removed by cutting above the clamped area. The uterine horn was 
closed by suturing it using absorbable sutures (Ethicon PDS*II). The uterine horn was 
then returned into the abdomen, and the process was repeated on the other side. The 
incisions were closed using absorbable sutures. Sham surgery involved making dorsal 




Figure 4.1. Surgical removal of ovary from SD rats. The picture shows the exteriorized 
fat pad in which the ovary is located and the use of mosquito forceps to crush the 
fallopian tube.  
 
Four rats from SHAM group were euthanized by carbon-dioxide asphyxiation 
immediately after surgery. Every four weeks, four animals each from SHAM and OVX 
were euthanized. The long bones (two femurs and two tibias) were harvested, wrapped in 
0.9% saline soaked guaze and stored at -20 oC until they are used for experiments. 
Previous studies on osteoporotic bone fractures using rat models revealed that the 
common facture site of long bones is the metaphysis (Stürmer et al. 2006) where a rapid 
deterioration of trabecular bone is observed (Yeni et al. 2004). Thus, it is appropriate to 
determine the degree of osteoporosis at the trabeculae-rich metaphysis of long bones by 
bending tests (Stürmer et al. 2006, Stuermer et al. 2010) and 3D micro-architectural 




Micro-computed tomography (microCT) 
The metaphysis regions of the proximal tibia and distal femur were scanned ex 
vivo in an upright position using SMX-100CT microCT scanner (Shimadzu, Kyoto, 
Japan) and Skyscan 1076 microCT scanner (Skyscan, Belgium), respectively. A source to 
object distance (SOD) of 41 mm and 128 mm and a source to image distance (SID) of 
339 mm and 161 mm were set for tibia and femur, respectively. For tibia, a 3.29 mm-
thick volume of interest (VOI) was obtained at 1 mm distal to the proximal growth plate, 
whereas for femur, 3.6 mm-thick VOI was selected 1 mm above the distal growth plate 
(Figure 4.1) (Campbell et al. 2008). The VOI for both tibia and femur included 200 CT 
slices. The resultant grayscale images of tibia and femur had a nominal resolution of 
16.47 µm and 17.75 µm, respectively, obtained from the cone-beam reconstruction (46 
kV, 49 µA and 100 kV, 100 µA for tibia and femur, respectively). 
The trabecular bone was selected from the cortical bone using a semi-automated 
contouring method employing dual thresholds (Muys et al. 2006) with erosion and 
dilation kernels of size 3 to remove cortical porosities and reconnect marrow cavities. 
The CT Analyzer software (Skyscan, Phil Salmon) was used to segment the grayscale 
images with a global threshold of 15% of the maximum gray scale value (Rho et al. 
1997) and the trabecular micro-architectural indices namely, bone volume fraction 
(BV/TV), structural model index (SMI), trabecular porosity (Tb.Po), trabecular thickness 
(Tb.Th), trabecular separation (Tb.Sp) and trabecular number (Tb.N) were calculated for 





Peripheral quantitative computed tomography (pQCT) 
Geometric and densitometric properties of the OVX and SHAM long bones were 
assessed using StraTEC’s XCT machine (Research SA+, StraTEC Medizintechnik, 
GmbH, Pforzheim, Germany). An initial scout view scan enabled exact positioning of the 
bone specimens and selecting the VOI. The VOI of pQCT scan is similar to that of 
microCT scan i.e., 1 mm below the proximal growth plate for tibia and 1 mm above the 
distal growth plate for femur. pQCT scanning were carried out with a pixel size of 100 
µm, slice thickness of 500 µm and inter-slice distance of 750 µm. A threshold of 280 
mg/cm3 was used to differentiate soft tissue from bone and an inner threshold of 550 
mg/cm3 was used for separating trabeculae from cortical bone. The mineral density 
measurements were averaged from five adjacent slices at the VOI. Three types of 
volumetric bone mineral density were obtained namely the mean BMD, trabecular 
density (Tb.BMD) and cortical density (Ct.BMD). The cortical area (Ct.Ar), cortical 
thickness (Ct.Th), periosteal perimeter (Ps.Pm) and endocortical perimeter (Ec.Pm) were 
measured for both femurs at the VOI.  
Mechanical testing 
A protocol from Stürmer et al. (2006) was adopted for the 3-point bending tests 
on tibia. The tibia bones were thawed and moistened continuously with phosphate 
buffered saline (PBS). 3-point bending test was carried out on metaphyseal tibia using a 
micro-testing machine (Instron 5848, Norwood, USA) with a measuring range was 2 N to 
1000 N and a precision of 0.2% of the load. The bone was placed with three-point contact 
on the aluminium base (block of 30 mm width, 14 mm height and 65 mm length). One 
side of the aluminium base consists of 3 rounded notches (1 mm deep; 2, 3 and 4 mm in 
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diameter), which were used to fix the end of proximal distal tibia and also prevent 
slipping of the bone during the breaking test. The posterior distal end of the tibia was 
placed on the other side of the aluminium base. The stamp is an axle-led aluminium roller 
of 8 mm diameter, with a central semi-circular notch of 1 mm radius. The movable base 
was adjusted so that the center of the roller stamp was at 3 mm distance from the 
proximal end of tibia. The stamp was driven down to the ventral metaphysis of the tibia 
until the preliminary strength of 1 N was reached. After a final visual check on the tibia 
position, the breaking test was conducted. The experiment was programmed to 
automatically end if, (i) strength drop is greater than 20 N and (ii) linear displacement is 
greater than 2 mm. Merlin software was used to calculate maximum load (Fmax), yield 
load (Fy) and stiffness (S) from the force-displacement data. The yield load was 
determined by the 0.2% offset method.  
Nanoindentation testing 
Nanoindentation tests were conducted on rat femurs using G200 Nanoindenter 
(Agilent Technologies Inc., Chandler, AZ). Samples were prepared by embed-cut-polish 
technique. Harvested rat femurs were positioned on its distal condyles with its long axis 
perpendicular to the base, and embedded in epoxy resin. After overnight hardening, the 
sample was precisely cut at the VOI (1 mm above the distal growth plate) using Isomet 
1000 precision saw (Buehler, USA). The samples were then ground using a series of 
silicon carbide paper of increasing grit size (320, 500, 1200 and 4000). Subsequent 
polishing was carried out using micro cloths and alumina bead suspensions of size 3 µm 
and 1 µm. After 16 hours of rehydration with 0.9% saline, the samples were subjected to 
nanoindentation tests at room temperature (26 oC), using a pyramidal Berkovich diamond 
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indenter. A total of 30 indents were produced on each sample. Continuous Stiffness 
Measurement (CSM) and basic creep tests were paired to obtain elastic modulus (E), 
hardness (H) and viscosity (), in a single set of test. 
Continuous Stiffness Measurement (CSM): This is a semi dynamic mode of indentation 
that involves superimposing an oscillating force of 45 Hz on top of the loading signal. 
This allows measuring the contact stiffness at any point during the loading curve and not 
just at the point of unloading as in conventional measurements (Shih and Rothfield 2006). 
E and H were calculated using the continuous measure of the contact stiffness. All 
measurements were taken at the depth range of 800 – 1000 nm in order to eliminate the 
interference of surface roughness for shallow indentations. Bone was assumed to be 
isotropic with a Poisson’s ratio of 0.3. E and H were determined individually for cortical 
and trabecular bone, as cortical elastic modulus (Ec), trabecular elastic modulus (Et), 
cortical hardness (Hc) and trabecular hardness (Ht). 
Basic XP creep: η of the bone was determined using creep test, which involves holding 
the indentation at maximum load (6 mN) for 100 s after achieving the designated 
displacement. The indenter tip was then unloaded to 10% of the maximum load and held 
for another 50 s for thermal drift measurements. η was computed by fitting the creep 
displacement-time curve to Voigt model (equation 4.1) by non-linear regression. 
                           
                                                                                                                                           4.1 
where, h(t) is the indentation creep displacement as a function of time, α is an equivalent 
cone semi-angle (70.3°) to the face angle of the Berkovich indenter (65.27°), E2 is an 




















Scanning electron microscopy (SEM) 
After nanoindentation tests, the epoxy-embedded samples were polished and 
etched in a hydrogen peroxide solution (35% H2O2) at 40 oC for two hours. Following 
etching dehydration was carried out by immersing the samples in different concentrations 
(50%, 70%, 90% and 100%) of ethanol solution. The samples were then glued on to stubs 
for SEM and coated with thin layer of gold. The nano-level structure of cortical bone was 
examined by scanning electron microscopy (FE-SEM, Philips XL series, Netherlands). 
Statistical Analysis 
Statistical analyses were carried out using SPSS v16 software and all the results 
are reported as meanSD (standard deviation). One-way analysis of variance (ANOVA) 
was performed by time to determine significant difference between different groups for 
each time point. Similarly, one-way ANOVA was performed by group to determine 
significant differences within each group over the time period. Bonferroni post-hoc 
corrections were used for all comparisons. Statistical significance was assumed at p value 




Rat weight gain 
Week 0 of the study did not exhibit significant difference in the weights of all the 
experimental rats. However, after four weeks, OVX group (338.8±18.1 g) rats exhibited 
higher body weight than the SHAM group (294.3±16.6 g) with statistical significance 
(p=0.04). Compared to week 0 rat weight, the OVX group showed significant weight 
gain by 2 week post-surgery (p=0.009) whereas SHAM group started showing significant 
weight gain only from week 8 (p=0.007).  By the end of 12 weeks, the overall weight 
gain was observed as 29.3% for SHAM (p=0.013) and almost double (54.9%) for OVX 
group (p<0.001). 
Micro-architectural analysis 
Three dimensional microCT rendered images of proximal femur and distal tibia of 
OVX and SHAM groups at week 12 post-surgery are shown in Figure 4.2. Ovariectomy 
induced deterioration of trabecular bone could be observed from the images. The 
corresponding changes in the micro-architectural indices of trabecular bone are 
represented in Figure 4.3 and 4.4 for tibia and femur, respectively. OVX group started to 
exhibit significant difference from SHAM group in terms of both tibia and femur micro-
architectural indices, starting from week 8 post-surgery. On week 12 post-surgery, OVX 
group tibia showed significantly decreased BV/TV (-61.8%) and Tb. N (-57%) and 
increased Tb.Po (+46.5%), Tb.Sp (+245.2%) and SMI (+129.3%) as compared to SHAM 
group. The trabecular micro-architectural deterioration was noticed earlier in femur 
metaphysis than the tibia. BV/TV, SMI, Tb.Po and Tb.Sp of femur metaphysis started 
showing significant difference from week 4 post-surgery and all the parameters showed 
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significant difference on week 8. Week 12 OVX femur showed significantly decreased 
BV/TV (-73.4%) and Tb.Th (-57.5%) and increased Tb.Po (+193.3%), Tb.Sp (+295.4%) 
and SMI (+111.4%) as compared to SHAM group. This signifies the extent of micro-
architectural deterioration of trabecular bone at both tibia and femur metaphysis. 
 
Figure 4.2. 3D microCT rendered images of rat femur and tibia showing the volume of 
interest (VOI) (left) and visualization of trabecular bone loss at the proximal tibial 




Figure 4.3. Changes in trabecular micro-architectural parameters of tibia, as measured by 
microCT: BV/TV, SMI, Tb.Po, Tb.Th, Tb.Sp and Tb.N of OVX and SHAM groups at 
different time points. * represents significant difference between SHAM and OVX group 
at a given time point.  
Figure 4.4. Changes in trabecular micro-architectural parameters of femur, as measured 
by microCT: BV/TV, SMI, Tb.Po, Tb.Th, Tb.Sp and Tb.N of OVX and SHAM groups at 
different time points. * represents significant difference between SHAM and OVX group 
at a given time point.  
90 
 
 All the microCT parameters of OVX femur showed significant difference from 
week 0 to week 4, 8 and 12. BV/TV and Tb.Th of OVX femur showed significant 
decrease from week 4 to week 8 and 12, but there was no marked reduction in these 
parameters from week 8 to week 12. This indicates that these parameters reached plateau 
following week 8. All other measured microCT parameters (SMI, Tb.Po, Tb.Sp and 
Tb.N) did not show any significant difference from week 4 to week 8 and 12, reaching 
plateau earlier from week 4 onwards. The lack of significant difference in the microCT 
parameters indicates that the rapid deterioration of trabecular micro-architecture reaches a 
plateau from week 8 to 12. 
Densitometric analysis 
pQCT rendered cross-sectional images of five adjacent slices at femur VOI of 
both SHAM and OVX group are represented in Figure 4.5. It can be observed from the 
images that OVX femur bone showed lesser trabeculae with large hollow bone marrow 
region, whereas the SHAM bone shows highly dense trabecular bone. Corresponding 
values of mean BMD, Tb. BMD and Ct. BMD of the tibia and femur bones are 
represented in Figure 4.6 and Figure 4.7, respectively. OVX group started to show 
significant decrease in mean BMD of both femur and tibia, starting from week 4 post-
surgery. On week 4, the tibia of OVX group showed 26% decrease in BMD as compared 
to the SHAM group (p<0.001) , which further reached a plateau (24.7% and 21.4% 
decrease on week 8 and 12, respectively). Femur of OVX group also showed similar 
trend with a significant 23.2% decrease on week 4 post-surgery, as compared to SHAM 
group (p<0.001) which further reached a plateau (25.5% and 25.6% decrease on week 8 




Figure 4.5. pQCT rendered cross sectional images of five adjacent pQCT slices at the 
VOI of 12 week OVX and SHAM femur bone shows a healthy highly dense (cyan/white) 
trabecular bone in SHAM group and larger bone marrow with lesser dense (red/yellow) 
trabecular bone in OVX group. 
 
Tb.BMD of OVX group showed a steady decreasing trend for both femur and 
tibia. A significantly lower Tb.BMD (-36.5%, p<0.01) was observed in OVX tibia as 
compared to SHAM group on week 4 post-surgery. On week 8 and 12 post-surgery, there 
was further decrease in Tb.BMD of OVX tibia, as compared to SHAM (56.1% and 
58.1% decrease on week 8 and 12, respectively). Similar trend was observed for Tb.BMD 
of OVX femur, with a 30%, 38.6% and 50.9% decrease as compared to SHAM group on 
week 4, 8 and 12, respectively (p<0.01). Significant differences in Ct.BMD were not 
observed between OVX and SHAM groups for tibia at any time point. However, OVX 
femur Ct.BMD showed a significant increase as compared to SHAM group on weeks 8 




Figure 4.6. Changes in mean BMD, Tb.BMD and Ct.BMD of tibia bone of SHAM and 
OVX groups at different time points, as measured by pQCT. * represents significant 




Figure 4.7. Changes in mean BMD, Tb.BMD and Ct.BMD of femur bone of SHAM and 
OVX groups at different time points, as measured by pQCT. * represents significant 




The geometric parameters of the cortical metaphyseal femur of SHAM and OVX 
groups are given in Table 4.1. The Ec.Pm of OVX group was observed to be significantly 
higher than that of SHAM group as early as 4 weeks post-surgery (p=0.048). All other 
geometric parameters, namely, Ps.Pm, Ct.Ar and Ct.Th showed significant difference 
between SHAM and OVX groups on week 12. At week 12 post-surgery, OVX showed 
significant increase in both Ps.Pm (+6.6%, p=0.001) and Ec.Pm (+16.9%, p<0.001), as 
compared to SHAM. However, the net result of these changes was a decreased Ct.Ar (-
12.1%, p=0.037) and Ct.Th (-19.4%, p=0.001) in OVX group as compared to SHAM 
group.  
Viscoelastic analysis 
Figure 4.8 represents changes in the Ec, Et, Hc, Ht and  of SHAM and OVX 
groups at different time points of the study. Significant decrease in Ec of OVX group as 
compared to SHAM group (-21.6%, p<0.001) was observed as early as four weeks post-
surgery. This difference was further maintained on week 8 and 12. Statistically 
significant difference in Et between SHAM and OVX group was not observed at any time 
point. Similarly, Hc of OVX showed a significant decrease on week 4 (-13.5%, p=0.047) 
and week 8 (-15.1%, p=0.009), as compared to SHAM group. However, Ht did not 
exhibit any significant difference between SHAM and OVX groups. Cortical  analysis 
revealed significant difference between SHAM and OVX group at all the time points 
(p<0.001), with OVX group having lower viscosity values than SHAM group.   of OVX 




Table 4.1.  Changes in the geometrical parameters of SHAM and OVX femur, as 
measured by pQCT. The results are represented as mean ± SD. 
 
Variables Weeks after surgery 
Groups 
    SHAM     OVX 
Ct.Ar 0 6.19 ± 0.76  
(mm2) 4 8.47 ± 1.27 6.74 ± 0.73 
 8 8.10 ± 0.74 7.28 ± 0.79 
 12 7.45 ± 0.43 6.55 ± 0.54 * 
    
Ct.Th 0 0.50 ± 0.05  
(mm) 4 0.72 ± 0.26 0.50 ± 0.08 
 8 0.65 ± 0.10 0.54 ± 0.05 
 12 0.62 ± 0.04 0.50 ± 0.06 * 
    
Ps.Pm 0 13.91 ± 1.41  
(mm) 4 14.36 ± 0.40 15.27 ± 1.14 
 8 14.65 ± 0.48 15.10 ± 0.48 
 12 14.04 ± 0.48 14.97 ± 0.33 * 
    
Ec.Pm 0 10.75 ± 1.51  
(mm) 4 9.79± 1.95 12.15 ± 1.48 * 
 8 10.59 ± 1.07 11.69 ± 0.24 
 12 10.17 ± 0.64 11.89 ± 0.60 * 
 
Ct.Ar = cortical area 
Ct.Th = cortical thickness 
Ps.Pm = periosteal perimeter  
Ec.Pm = endocortical perimeter 







Figure 4.8. Changes in Ec, Et, Hc, Ht and  of SHAM and OVX groups at different time 
points as measured from nanoindentation tests. * represents significant difference 







 Figure 4.9 shows the SEM images of the cortical bone of the femur metaphysis of 
SHAM and OVX groups at the VOI. An observable change in the cortical bone surface 
morphology could be observed from the images. The cortical bone of the SHAM group 
shows densely packed surface of hydroxyapatite particles that grow tightly on the fibrous 
collagen matrix. OVX group cortical surface shows the cortical bone deterioration with 
looser bone structure with micropores and nanovoids. 
 
Figure 4.9. SEM surface images of the cortical bone at the VOI of femur metaphysis for 
OVX and SHAM groups, at 10,000X magnification. 
 
Mechanical analysis 
Figure 4.10 represents the changes in Fmax, Fy and S of tibia of the SHAM and 
OVX groups at different time points, as measured from the three-point bending tests. 
There was a significant 69.9% increase in Fmax of SHAM group from week 0 to week 12 
post-surgery. This increase could be primarily due to the growth of bone in SHAM group 
rats. However, OVX group did not show any increase in Fmax during the course of the 
study. On week 4, 8 and 12 post-surgery, OVX tibia exhibited significantly lower Fmax as 
97 
 
compared to the same week SHAM. Fy exhibited significant decrease in OVX group, as 
compared to SHAM group (p<0.05) on week 8 and 12 post-surgery. The OVX bone Fy 
significantly decreased from week 0 to week 12 by 18.2% (p<0.05). On the other hand, S 
of OVX group decreased by 38.9% from week 0 to week 12 post-surgery. On week 12 
post-surgery, S showed significant difference between OVX and SHAM group (p<0.05). 
 
 
Figure 4.10. Changes in the Fmax, Fy and S of the SHAM and OVX groups at different 
time points, as determined from three point bending tests. * represents significant 







The increased incidence of osteoporotic fractures, especially in elderly population 
instigates the requirement to study the pathogenesis of osteoporosis, treatment efficacy 
and safety using animal models. Ovariectomized rat models are the most often used 
animal models to study postmenopausal osteoporosis with estrogen deficiency, because 
of their numerous advantages, such as: low cost, easy and safe to handle, rapid generation 
time, little maintenance requirements, reliable reproducibility of disease and lesser ethical 
issues (Yoon et al. 2012, Lelovas et al. 2008). There are extensive studies on 
ovariectomy-induced histomorphometric and biochemical changes of bone turn over 
(Sheng et al. 2007, Lei et al. 2009, Shiraishi et al. 2009, Yoon et al. 2012, Lelovas et al. 
2008). This study attempted to extensively investigate ovariectomy-induced changes in 
bone properties in 3 months old rat models, in terms of micro-architectural, 
densitometric, geometric, mechanical and viscoelastic analysis. The changes in bone 
quality in the ovariectomy induced osteoporotic condition were assessed through 
microCT, pQCT, three-point bending and nanoindentation tests. The implications of this 
study would shed light on the ovariectomy-induced changes on different aspects of bone 
quality that could provide insights into the pathophysiology of early stage of 
osteoporosis.  
 In trabecular micro-architecture and trabecular density analysis, both microCT 
and pQCT results revealed that ovariectomy-induced osteopenia in rat models were 
associated with deterioration in trabecular micro-architecture and decreased bone mineral 
density in both femur and tibia. Tb.BMD of both femur and tibia showed significant 
reduction as soon as 4 weeks post-surgery. Most of the micro-architectural parameters 
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started showing significant changes from 8 weeks post-surgery. These results are 
consistent with previous studies, which reported irreversible micro-architectural changes 
happening during 8-12 weeks post-surgery (Campbell et al. 2008). Reduced BV/TV as 
measured by microCT bears implications for reduced strength and stiffness of trabecular 
bone (Nazarian et al. 2008). Changes in Tb.Th, Tb.Sp and Tb.N revealed the reduced 
average thickness of trabeculae struts, increased mean distance between adjacent struts 
and reduced number of trabecular strands in OVX group. Changes in SMI implied that 
the trabecular struts have become more rod-like in OVX group as opposed to the plate 
like structure in SHAM group. Similar to the literature data (Boyd et al. 2006, Campbell 
et al. 2008), leveling off of the micro-architectural indices from week 8 to 12 can be 
observed in OVX data, suggesting that following ovariectomy there was early and drastic 
changes in the trabecular micro-architecture that reaches a plateau after from week 8 
post-surgery. Early, drastic and irreversible structural changes following estrogen 
deficiency in ovariectomized rat models illustrate the importance of early administration 
of osteoporosis treatments for better prevention.  
 In terms of whole bone properties, mean BMD and Fmax of tibia started showing 
significant differences as soon as 4 weeks post-surgery. Fy and S showed significant 
differences at later time points. Thus, reduced mean BMD still corresponds well with 
mechanical testing results from three-point bending. This suggests that BMD 
measurements could still predict the overall mechanical property of the bone. It was 
observed that the standard deviation of the three-point bending results was huge. This 
could be due to the still-maturing skeleton of the considerably young rats, used for this 
study. Also, different kinds of fractures such as the metaphyseal oblique fracture, the Y-
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fracture and condyle fracture, as observed by Stürmer et al (2006) were not individually 
analyzed in the three-point bending tests due to limited sample size per group. This could 
contribute to the diversified mechanical testing results and hence a higher standard 
deviation. Nevertheless, it could be observed clearly that the mechanical performance of 
OVX tibia has significantly reduced and these changes were in agreement with reduced 
mean BMD. Thus, the conventional clinical index for osteoporotic fracture prediction, the 
BMD, could still be considered as a bone strength predictor. As the Ct.BMD of tibia did 
not show any significant difference at any time point of the study, it is also worthwhile to 
note that the reduced mean BMD of tibia was primarily due to the reduced Tb.BMD 
rather than the Ct.BMD. On the other hand, despite a significant increase in Ct.BMD 
observed in femur metaphysis, the mean BMD still reduced mainly due to the reduced 
Tb.BMD. Thus, reduced BMD of OVX rat bones, as observed from this study, accounts 
mostly from the trabecular bone loss rather than the cortical bone changes, if any.  
 Although macroscopic deterioration of bone mass and structure are crucial for 
bone strength, the intrinsic tissue-level material properties of the bone are also crucial 
determinants of bone strength. The nanomechanical properties, as measured by 
nanoindentation tests showed significant changes in cortical bone of femur metaphysis. 
Ovariectomy caused significantly reduced elastic modulus and hardness of femur cortical 
bone at the metaphysis as compared to the SHAM group, as soon as 4 weeks post-
surgery. However, trabecular elastic modulus and hardness did not show any significant 
difference at any time point. This is in accordance with the previous studies that showed 
that nano-level mechanical properties of rat vertebral trabecular bone were not affected 
by ovariectomy (Guo and Goldstein 2000, Sheng et al. 2006). The trabecular and cortical 
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E and H values were comparable to previous studies using 6 months old rat models 
(Brennan et al. 2009, Maïmoun et al. 2012). However, there are certain studies on 
trabeculae of proximal femur of the ovariectomized ovine models, which demonstrated 
ovariectomy-induced reduction in intrinsic tissue modulus with no observable change in 
hardness (Brennan et al. 2009, Brennan et al. 2011). These studies suggest that intrinsic 
tissue properties of trabeculae could possibly be affected by estrogen deficiency, but such 
change was not greatly observable in rats due to inter-species difference in bone 
architecture. However, a recent study on ovariectomized rats (six-months old) showed a 
reduction in cortical hardness, trabecular modulus and hardness of vertebral bone after 40 
weeks of ovariectomy (Maïmoun et al. 2012). This contradiction with our present study 
could possibly be due to differences in age of the rats (3 months old rats), duration of our 
experiment (12 weeks) and different physiological location (femur). Our study primarily 
focuses on the changes in intrinsic tissue properties occurring during the early phase of 
ovariectomy, when rapid changes in micro-architecture occur. During this period, only 
cortical changes were more pronounced than the trabecular part. It is worthwhile to note 
that although Ct.BMD did not show any significant reduction, the intrinsic tissue property 
such as the modulus and hardness are significantly affected, which is also important for 
bone strength.  
 Certain studies revealed a strong positive correlation between indentation 
viscosity and indentation modulus (Kim et al. 2010, Kim et al. 2013). Accordingly, in 
this study, a reduction in cortical modulus was associated with similar reduction in 
cortical viscosity. The viscosity of the bone is important for the mechanical performance 
of bone, because a bone tissue with higher viscosity could have better absorption of 
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energy under loading (Isaksson et al. 2010). With its complex structure, the mechanical 
behavior of bone is determined by the type and arrangement of its different structural 
elements. Hard minerals, as reflected by BMD, can contribute to high strength and 
stiffness to resist compressive stresses and fracture, whereas compliant collagen fibers 
provide high toughness and viscoelasticity to retard fracture propagation under shear or 
tensile strength (Chang et al. 2011). Thus, the changes in viscosity of the tissue could be 
due to the changes in bone matrix of the cortical bone. Accordingly, the SEM images 
showed that the SHAM group contains densely packed structure of hydroxyapatite 
crystals. On contrary, estrogen deficiency resulted in a porous and randomly aligned 
matrix structure that could cause a poor viscoelastic behavior. Therefore, microcrack 
formation and its rapid propagation are more likely to occur. Thus, viscosity values could 
reflect the intrinsic bone matrix property and therefore, it could be a potential predictor of 
bone strength.  
 In addition to changes in cortical matrix following ovariectomy, there is also 
marked changes in the cross sectional geometry of cortical bone. OVX group was found 
to have both increased Ps.Pm and Ec.Pm, as compared the SHAM group, which signifies 
increased periosteal bone formaton and endocortical resorption following ovariectomy. 
This increased modeling of the bone could possibly occur to compensate the loss in 
trabecular density and architecture (Bagi et al. 1997). The net result of this modeling at 
periosteum and endocortex of OVX bone was a reduced cortical thickness and area.  
Apart from the changes in intrinsic tissue property of the trabecular bone, this reduction 
in cortical thickness and area could contribute to poor mechanical strength of 
ovariectomized rat bones.  
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 There are certain limitations to the study. First, there are discrepancies between 
rat and human cortical bone. Rat bone lacks Harversian remodeling. Subsequently, the 
results from this study might not have good compliance with the clinical observations of 
postmenopausal osteoporosis. Nevertheless, this study would provide details on possible 
changes in intrinsic cortical bone properties associated with early stage of osteoporosis. 
Although the rats use in this study are matured but young (3 months old), previous 
studies have successfully established effects of osteoporosis and treatment efficacy using 
a similar model (Stürmer et al. 2006, Bagi et al. 1997). Overall, it could be observed that 
ovariectomy induced deficiency of estrogen along with other gonodal hormones had 
different effects on cortical and trabecular bone. In the trabecular bone, there was rapid 
deterioration in micro-architecture associated with reduced BMD without apparent 
changes in their intrinsic property. On the other hand, although cortical bone did not 
show any deterioration in terms of BMD, the intrinsic tissue properties and geometry of 





4.5. Conclusions  
The major conclusions of the study are summarized as follows. 
 Following ovariectomy induced estrogen deficiency in rats, rapid and irreversible 
deterioration of trabecular micro-architecture occurs early, and further reaches a 
plateau. This emphasizes on starting earlier treatment regimens for postmenopausal 
osteoporosis.  
 Reduction in mean BMD was observed primarily due to trabecular bone loss and does 
not reflect the cortical part. Reduction in BMD still corresponds to reduced Fmax, 
indicating that BMD could still be considered a potential predictor of bone strength. 
 Intrinsic bone properties such as elastic modulus and hardness of the cortical bone was 
significantly affected by estrogen deficiency, whereas, trabecular bone intrinsic 
properties did not show any significant changes. Thus, despite an 
increasing/unchanging cortical BMD, the intrinsic tissue properties of cortical bone 
were significantly influenced by estrogen deficiency in rats. 
 Ovariectomy also caused reduced viscosity of cortical bone and therefore poor 
viscoelastic properties. The changes in viscosity correspond to changes in bone matrix 
structures. Viscosity could be an indicator of micro-fracture propagation of bone, but 
it requires a large-scale study. 
 Poor cortical bone geometry following ovariectomy , due to increased periosteal 
formation and endocortical resorption could further contribute to poor bone strength. 
 Overall, the trabecular and cortical bones were affected in a different manner 












IN VIVO: EFFECT OF 















The previous chapter summarizes the effect of ovariectomy on tissue-level bone 
properties. In this chapter the effect of ovariectomy on cellular level properties were 
studied. From previous chapter it was understood that rapid micro-architectural 
deterioration occurs early in the ovariectomized rat model. By adopting the same animal 
model, the changes in properties of primary bone cells were studied during this period of 
rapid deterioration. This chapter will summarize the effect of ovariectomy on the isolated 
primary bone cells from rat bones, in terms of their mechanical and structural properties. 
The direct effects of estradiol on these primary bone cells were also studied. 
5.1. Introduction 
 The effect of osteoporosis on the tissue-level bone properties such as 
histomorphometric, structural, mechanical and viscoelastic changes of bone quality has 
been thoroughly investigated (Yang et al. 2012, Yang et al. 2011, Brennan et al. 2009).  
However, the cellular level changes during the pathogenesis of osteoporosis are still 
poorly understood. The increased osteoclastic activity of excessive bone resorption was 
hypothesized to be the important cause of osteoporosis. (Oursler et al. 1991, Novack 
2007). However, certain studies showed that osteoblastic activity play a more important 
role in the pathogenesis of osteoporosis as the expression of osteoprotegrin, receptor 
activator of NF-κB ligand (RANKL), bone morphogenetic proteins and cytokines by 
osteoblasts influences the activity of osteoclasts (Lerner 2006).  
 Most of the studies on the role of osteoblasts in osteoporosis pathogenesis use in 
vitro analysis of osteoblasts-like cells and ex vivo histological analysis of bone tissue of 
osteoporotic animals and patients (Bradford et al. 2010, Ireland et al. 2002, DiSilvio et al. 
2006, Ikeda 2008, Jilka 2003). In vitro assessment of osteoblasts with different treatments 
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of metabolites and drugs does not consider the involvement of many influential factors in 
vivo. Our previous study on in vitro assessment of direct effect of estradiol on osteoblasts 
infers a possibility that pathogenesis of osteoporosis could be associated with changes in 
osteoblasts’ mechanical and structural properties (Muthukumaran et al. 2012). However, 
this study did not consider several in vivo influences on osteoblasts cells during the 
pathogenesis of postmenopausal osteoporosis, apart from deficiency of estrogen. 
Therefore, in this study, we aimed to assess the changes in osteoblasts mechanical and 
structural properties due to in vivo loss of estrogen, leading to pathogenesis of 
osteoporosis.  
 In this study, we used the previously characterized ovariectomized rat model to 
study the ovariectomy associated changes in the mechanical, structural and functional 
properties of osteoblasts. Studies on single cell mechanics are gaining importance in 
understanding the difference between diseased state cells and healthy ones (Lim et al. 
2006, Li et al. 2008). Bone cells are particularly interesting for studying single cell 
mechanics because bone tissue is known to respond continually to the externally applied 
mechanical forces by adapting its shape and architecture (Morgan et al. 2008, Lee et al. 
2002, Garner et al. 2000). The response of bone tissue to intermittent mechanical loads 
involves changes in bone remodeling to deposit new bone in the direction of functional 
stresses (Wolff 1986, Chamay and Tschantz 1972). At cellular level, osteocytes and 
osteoblasts act as mechanosensors of bone and respond to mechanical forces through 
functional changes and altered bone remodeling (Westbroek et al. 2000, Vezeridis et al. 
2006, Ban et al. 2011, McGarry et al. 2008). It was therefore assumed that mechanical 
integrity of mechanosensitive osteoblasts is important for their function. Therefore, we 
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aim to study the changes in mechanical property of the osteoblasts due to ovariectomy, 
along with other functional changes of the cells. 
 In this study, Atomic Force Microscopy (AFM) was used to assess the mechanical 
property of osteoblasts. Invented in 1986 by Binning et al, AFM soon became a valuable 
and useful tool for imaging and as a force sensor with piconewton force resolution, thus 
making it a potential tool to study single cell mechanics (Binning and Quate 1986). AFM 
is widely used to probe the micromechanical properties of soft living cells in their 
physiological environment (Lim et al. 2006, Li et al. 2008, Kuznetsova et al. 2007, Zhang 
et al. 2008, Jaasma et al. 2006, Muthukumaran et al. 2012). Overall, this study analyzes 
the structure-mechanical property-function relationship of osteoblasts cells isolated from 
normal and osteopenic rats. Apparent elastic modulus (E*) of the osteoblasts was 
quantified using AFM and compared to corresponding changes in F-actin cytoskeletal 




5.2. Materials and Methods 
Animal work 
Eight female Sprague-Dawley rats (Laboratory Animal Centre, National 
University of Singapore) of age 3 months were housed at 25 oC under a 12:12-hour light-
dark cycle. They were fed a standard rodent diet (Harland, Model T.2018S) and water ad 
libitum. All animal experiments were conducted in accordance with the approved 
protocol from the Institutional Animal Care and Use Committee (IACUC) at National 
University of Singapore. The rats were randomly divided into 2 groups namely OVX 
(n=4) and SHAM (n=4) and they were subjected to bilateral ovariectomy or sham 
surgery, respectively, after one week of acclimatization. After four weeks, the rats were 
euthanized by carbon-dioxide asphyxiation. The long bones (two femurs and two tibias) 
were harvested, soaked in PBS (phosphate buffered saline) containing 1X antibiotic-
antimycotic solution (PAA laboratories Ltd.) and used for primary bone cell culture 
protocol within 30 minutes.  
Primary bone cell culture 
The primary cell culture procedure was carried out under aseptic conditions in a 
biosafety laminar flow hood. The soft tissues around the bone were thoroughly cleaned 
from the harvested rat bones, by scraping on the bone surface using sterile scalpel of size 
11. The long bones were cut into small pieces of dimensions less than 5 mm. Bone pieces 
were consequently washed vigorously in PBS containing 2X antibiotic-antimycotic 
solution for 3 cycles. 4-5 bone explants were then placed in each well of a 6 well tissue 
culture plates. Osteogenic medium comprising of DMEM medium (Invitrogen), 
supplemented with 10% fetal bovine serum (Hyclone sera), 1X antibiotic-antymycotic 
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solution and 100 μM L-Ascorbate (Sigma Aldrich) was added to the explants and grown 
at 37 oC in a carbon-dioxide incubator (Sanyo). Medium was partially replaced every 3-4 
days. The cells would get exuded from bone surface to the medium and subsequently gets 
attached to the substratum of the tissue culture plate and start growing (Figure 5.1. A). 
The explants were thus maintained for at least 3-4 week, until the confluency of bone 
cells were reached (Figure 5.1. B). Following that, the bone cells were trypsinized, 






Figure 5.1.A. Day 3 after primary bone cell culture – Cells start oozing out from the 
surface of the bone explants to the culture medium as indicated by black arrows. The 






Figure 5.1.B. Day 14 and 28 after bone cell culture shows corresponding confluency of 
cells. The cells are most often found to grow as separate clusters as shown in the first 
picture, these cluster grow radially to cover the surface of culture plates to reach 100% 
confluency. 
 
Alkaline Phosphatase activity  
2 x 104 primary bone cells from both SHAM and OVX group were seeded onto 
the 24 well tissue culture plates and the cells were grown to confluency for 3 days in the 
osteogenic medium in the presence and absence of 10 nM β-estradiol (Sigma Aldrich). 
The alkaline phosphatase activity of the confluent cells was analyzed using the alkaline 
phosphatase reagent (Alkaline Phosphatase Yellow (pNPP) Liquid Substrate System for 
ELISA, Sigma Aldrich). After 30 minutes of incubation with the reagent at 37 oC in the 
carbon-dioxide incubator to yield a yellow enzymatic reaction product, 50 µl of 3N 
NaOH was added to stop the reaction. Absorbance was measured at 405 nm using a 
microplate reader (FLUOstar OPTIMA, BMG labtech). Visualization of cells with 
alkaline phosphatase activity was achieved by tagging the cells with ELF 97 phosphatase 
substrate (Life Technologies), which produces fluorescent green precipitate on 
hydrolysis. Thus, ELF 97 substrate causes green fluorescence at the site of alkaline 
phosphatase activity. Images were taken using Evos Fl microscope (Advanced 




2 x 103 primary bone cells from both SHAM and OVX group were seeded into a 
96 well tissue culture plates and were grown in the osteogenic medium in the presence 
and absence of 10 nM β-estradiol. MTT assay was carried out on day 1 and day 4 
following seeding to assess the proliferation rate during the 3 days. MTT assay was 
carried out by adding 10 µl of 5 mg/ml of 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide solution to each well. After 4 hours of incubation at 37 oC 
in the carbon-dioxide incubator, the medium was removed and 100µl of DMSO was 
added to each well. The absorbance was then measured at 570 nm using the microplate 
reader.  
AFM force indentation 
For AFM force indentation, 2 x 104 primary cells from both SHAM and OVX 
group were seeded on to 13 mm glass cover slips (Heinz glass), kept in a 24 well tissue 
culture plate, and grown in the osteogenic medium in the presence and absence of 10 nM 
β-estradiol. After growing the cells for 3 days in a carbon-dioxide incubator, the cells 
were subjected to AFM force indentation. A nanoscope IV multimode AFM with a 
picoforce scanner (Digital Instruments Inc) was used to probe the elastic modulus of the 
cell. The cells grown on the 13 mm glass cover slip served as the sample for analysis. 
This sample was mounted on the AFM stage and the cells were kept immersed in PBS 
using a standard fluid cell (Digital Instruments Inc, USA), throughout the experiment. 
For measuring the whole cell mechanical property, instead of the conventional sharp tip, 
a modified silicon nitride AFM cantilever of spring constant 0.03 N/m with a spherical 
polystyrene bead of diameter 4.5 µm adhered to the tip (NovaScan technologies, USA) 
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was used for AFM indentation. Force indentations with spherical bead indenters offers 
many advantages such as assessment of the elastic modulus of the cell by averaging over 
a larger surface area of contact and reduced local strains on the contact surface during 
indentation that reduces the non-linear or destructive deformation of the cell (Li et al. 
2008). The cell was indented in its center at an indentation force threshold of 200 pN and 
at the rate of 0.1 Hz to ensure minimal indentation depth on cell surface that reduces 
substrate contributions (Li et al. 2008, Muthukumaran et al. 2012).  
From a single indentation of the spherical bead indenter onto the cells, the force 
displacement curve is traced using AFM. This curve contains the information about the 
force interaction between the tip and the sample surface as a function of relative tip-
sample distance during the indentation of tip on the cell surface. Sneddon’s mechanics 
was employed to determine the apparent elastic modulus (E*) of the primary bone cells. 
First, a force curve was recorded by indenting the tip on the substrate as reference. Later, 
another force curve was generated by indenting the cells. The difference between these 
two deflections is a measure of the indentation depth of the probe into the cells (h). The 
apparent elastic modulus (E*) of the sample can be determined from the force (F) versus 
indentation (h) curve using equation 5.1. From Hertzian contact law, the force can be 
related to the indentation as,                                                  
      * 3/24 3
RF h E h               (5.1) 
where, R is the radius of the spherical bead (2.25 µm), used to indent the sample. From 




Phalloidin and DAPI staining 
The cells were first washed with PBS and fixed using 4% paraformaldehyde 
(PFA, Sigma Aldrich) for 15 minutes. The cells were then permeabilized by treating with 
0.2% Triton-X 100 (Promega pte ltd, USA) for 10 minutes. The F-actin filaments were 
stained by incubating with 0.1 µg/ml TRITC-Phalloidin (Sigma Aldrich) for 45 minutes 
in dark. The nuclei was stained with 4',6-diamidino-2-phenylindole (DAPI, Sigma 
Aldrich) for 15 minutes. The images were taken using Evos fl microscope. The F-actin 
and nuclei were quantified by measuring the fluorescence intensity using a microplate 
reader (FLUOstar OPTIMA, BMG labtech). The fluorescence intensity for F-actin 
(TRITC component) was measured at an excitation wavelength of 544 nm and emission 
filter of 590 nm. DAPI was measured at an excitation and emission wavelength of 355 
nm and 460 nm, respectively. 
Staining for type I collagen 
 2 x 104 primary bone cells from both SHAM and OVX group were seeded onto 
the 24 well tissue culture plates and the cells were grown to confluency in the osteogenic 
medium in the presence and absence of 10 nM β-estradiol. After 14 days of confluency, 
the cells were fixed with ice cold methanol (-20 oC). 3% of bovine serum albumin (BSA, 
Sigma Aldrich) was used to block the substrate surface. Following that, the samples were 
incubated with 200 µl of Monoclonal Anti-Collagen Type I antibody (produced in mouse, 
Sigma Aldrich) for 90 minutes at room temperature. After washing the samples with 
PBS, secondary antibodies (goat anti-mouse IgG-FITC, Sigma Aldrich) and DAPI 
solution were added and incubated for 45 minutes in dark at room temperature. After 




 Von Kossa assay was employed to assess the in vitro mineralization capability of 
the cells. 2 x 104 primary bone cells from both SHAM and OVX group were seeded onto 
the 24 well tissue culture plates and the cells were grown to confluency in the osteogenic 
medium in the presence and absence of 10 nM β-estradiol. After 14 days of confluency, 
the cells were fixed with 4% PFA (Sigma Aldrich), washed with distilled water and 
incubated with 1% silver nitrate (Sigma Aldrich) under ultraviolet light for 45 minutes. 
The cells were further washed with distilled water and treated with 3% sodium thiosulfate 
(Sigma Aldrich) for 5 minutes to remove unreacted silver. After washing with distilled 
water, images were taken using Olympus IX-71 inverted microscope. 
Statistical Analysis 
Statistical analyses were carried out using SPSS v16 software and all the results 
are reported as meanSD (standard deviation), except for AFM results, which are 
represented as mean±SEM (standard error of mean). One-way analysis of variance 
(ANOVA) was performed by time to determine significant difference between different 
groups. Bonferroni post-hoc corrections were used for all comparisons. Statistical 




Rat weight gain 
The summary of rat weights during the experimental period is given in Figure 5.2. 
Week 0 of the experiment did not show significant difference (p=1) in the body weight of 
different group rats. Compared to week 0, there was significant weight gain for both 
OVX (p<0.001) and SHAM (p=0.004) group after four weeks of surgery. This indicates 
that the rats are actively growing during the experimental period. By the end of 4 weeks, 
OVX group (347.3±14.7) showed significantly higher (p=0.002) body weight as 
compared to SHAM group (267.5±16.3).  
 
Figure 5.2. Summary of average rat weight during the experimental period. Error bar 
indicates standard deviation. # indicates significant difference (p<0.05) as compared to 
week 0 of same group. * indicates significant difference (p<0.05) between SHAM and 
OVX group. 
 
Primary osteoblasts culture 
 The isolated primary cells from rat long bones showed positive markers for 
osteoblastic cells. All the primary cell samples from OVX and SHAM rat bones were 
tested with ELF 97 phosphate substrate for visualization of cells with alkaline 
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phosphatase activity. Figure 5.3 represents cells tagged with ELF 97. All the primary cell 
samples were found to be similar heterogeneous culture with high density of osteoblastic 
cells with alkaline phosphatase activity. The cells also showed positive expression of 
collagen and mineralization. 
               
Figure 5.3. Bright field, green fluorescent and merged images of primary bone cell 
heterogeneous culture showing the expression of alkaline phosphatase by majority of the 




AFM force indentation 
A total of 31 cells from each group (SHAM and OVX group with and without 
estradiol treatment) were indented using the spherical bead indenter of radius 2.25 µm. 
E* was measured for all indentations and the averaged value of each group is represented 
in Figure 5.4. The primary bone cells isolated from OVX group showed significantly 
increased E* (+86.5%, p=0.007) as compared to the SHAM group. This indicates that the 
primary cells isolated from ovariectomized rats were stiffer than those from normal rats. 
Estradiol treatment did not cause significant difference in the stiffness of the primary 
cells from SHAM group (p=1). However, the primary cells from OVX group showed 
significantly decreased E* (-38.4%, p=0.039) on treatment with estradiol.  
 
Figure 5.4. Average elastic modulus of SHAM and OVX primary osteoblasts with and 
without estradiol treatment. Error bar shows standard error of mean. # indicates 
significant difference (p<0.05) between SHAM and OVX group. * indicates significant 






According to the tensegrity model, the filaments of actin cytoskeleton form a pre-
stressed mechanical network that determines the structure and stiffness of the cell 
(Houben et al. 2007). Thus, further investigation on the actin structures is crucial to 
understand the underlying reason for the changes in the stiffness of the cells. The 
representative images of primary bone cells of each group with F-actin labeled with 
phalloidin-TRITC are shown in Figure 5.5. Primary bone cells of OVX group showed 
denser and elongated actin filaments as compared to the SHAM group. On estradiol 
treatment, the F-actin filaments of the OVX group primary cells were observed to 
decrease in their density.    
Figure 5.5. F-actin staining of primary bone cells of SHAM and OVX groups with and 




 The changes in F-actin were quantified by measuring the fluorescence intensity of 
the cells following labeling with phalloidin-TRITC and DAPI. Fluorescence intensity for 
TRITC, which is representative of F-actin filament density, of different groups is 
represented in Figure 5.6. Primary bone cells of OVX group showed significantly higher 
F-actin density (23.7%, p=0.004) than that of SHAM group. SHAM group cells did not 
show significant difference in F-actin density on treatment with estradiol (p=1). 
However, OVX group showed significantly reduced F-actin density with estradiol 
treatment (-13.9%, p=0.042). The DAPI intensity of different groups (summarized in 
Table 5.1), did not show significant difference amongst them (p=1 for all comparisons). 
Fluorescence intensity for DAPI would indicate nucleus density and therefore would 
represent the cell density. Thus, the measured TRITC fluorescence intensity was not 
affected by difference in cell number and therefore, would indicate the density of F-actin 
filaments of individual cells. 
 
Table 5.1. Average fluorescence intensity for DAPI labeled primary bone cells of OVX 




Fluorescence intensity (355nm/460nm) 
SHAM OVX 
   
Control 132.6 ± 15.0 135.6 ± 15.3 
   
Estradiol 130.0 ± 12.5 134.0 ± 17.7 





Figure 5.6. Average fluorescence intensity of phalloidin-TRITC labeled primary bone 
cells from SHAM and OVX groups with and without estradiol treatment. Error bar shows 
standard error of mean. # indicates significant difference (p<0.05) between SHAM and 
OVX group. * indicates significant difference (p<0.05) on comparison with same group 
control treatment 
 
Alkaline phosphatase activity  
 Figure 5.7 represents the alkaline phosphatase activity of the confluent culture of 
primary bone cells isolated from SHAM and OVX group rats in the presence and absence 
of estradiol. It was observed that the alkaline phosphatase activity of the OVX group cells 
was significantly higher (+72%, p<0.001) than that of the SHAM group. On treatment 
with estradiol, the alkaline phosphatase activity of OVX group cells significant increased 
by 27.4% (p<0.001). However the alkaline phosphatase activity of SHAM group cells did 
not show significant differences on estradiol treatment (p=1). Eventually, following 
estradiol treatment, OVX group cells showed much higher alkaline phosphatase activity 





Figure 5.7. Alkaline phosphatase activity of the primary bone cells of SHAM and OVX 
groups in the presence and absence of estradiol. Error bar shows standard error of mean. 
# indicates significant difference (p<0.05) between SHAM and OVX group. * indicates 
significant difference (p<0.05) on comparison with same group control treatment 
 
Proliferation rate 
 The measured proliferation rate over 3 days of culture is summarized in Figure 
5.8. The proliferation rate of the primary bone cells of SHAM and OVX group did not 
show significant difference (p=1). On treatment with estradiol, the proliferation rate of 
the OVX group primary bone cells decreased significantly to almost half (p=0.002). 
However, SHAM group primary bone cells did not show statistically significant 






Figure 5.8. Proliferation rate over 3 days of the primary bone cells of SHAM and OVX 
groups in the presence and absence of estradiol. Error bar shows standard error of mean. 
# indicates significant difference (p<0.05) between SHAM and OVX group. * indicates 
significant difference (p<0.05) on comparison with same group control treatment 
 
Collagen expression 
 Figure 5.9 shows the collagen expression of primary bone cells following 14 days 
of confluency. The SHAM group primary bone cells showed higher expression of 
collagen than OVX group as seen from dense collagen expression on SHAM control 
group. Subsequently, estradiol treatment on SHAM group primary cells did not show any 
significant difference on collagen expression. OVX group showed much impaired 
collagen expression. On estradiol treatment, OVX group showed an increase in collagen 
expression. However, this expression of collagen was more sparse and uneven as 





Figure 5.9. Collagen type I of primary bone cells of SHAM and OVX groups with and 
without estradiol treatment, following 14 days of confluency. Scale bar indicates 400 µm. 
 
Mineralization assay 
Figure 5.10 shows the Von Kossa staining for mineralization of primary bone 
cells following 14 days of confluency. Although OVX group showed thicker deposits of 
mineralization, the SHAM group primary bone cells showed uniform mineralization that 
covered almost the entire culture surface. OVX group showed very sparse and thicker 
deposits. On estradiol treatment, OVX group showed increased mineralization as 
apparent from closer deposits, as yet sparser than SHAM group. SHAM group showed 




Figure 5.10. Von Kossa staining of primary bone cells of SHAM and OVX groups with 





 Our previous study on human fetal osteoblasts cell line showed that estrogen has a 
direct effect on the mechanical and structural properties of osteoblasts cells 
(Muthukumaran et al. 2012). This indicates the possibility that pathogenesis of 
postmenopausal osteoporosis, which occurs due to estrogen deficiency, would be 
accompanied by changes in the mechanical properties of osteoblasts in addition to the 
impaired physiological functions. Pathogenesis of postmenopausal osteoporosis is a 
complicated process, which involves several other physiological factors in addition to 
estrogen deficiency (Syed and Khosla 2005, Raisz 2005). The development of methods 
for culturing osteoblasts in vitro from bone explants has enabled the researchers to study 
bone metabolism in healthy tissue and different bone conditions (Yu et al. 2012). Thus, in 
order to understand the in vivo effects of postmenopausal osteoporosis, this study 
attempted to investigate the effect of in vivo loss of estrogen in the ovariectomized rat 
models on the mechanical and structural properties of primary bone cells cultured from 
the rat long bones. This study would shed insights on the mechanistic changes in the 
osteoblastic cells during pathogenesis of postmenopausal osteoporosis.  
 There are several osteoblasts-like cell lines available commercially. These cell 
lines were derived from osteosarcoma tissues and gene transfer methods and show good 
stability and purity. Osteoblasts-like cell lines derived from osteosarcoma shows 
differences in genetic response as opposed to osteoblasts cells (Harris et al. 1995). 
Commercial sources of osteoblasts-like cells could have undergone changes that may not 
adequately represent the normal physiological function of osteoblasts (Owen and Pan 
2008, Yu et al. 2012). It is also not possible to control and study the influence of in vivo 
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conditions from which the cells are isolated. Primary osteoblastic cultures derived from 
normal and osteoporotic human bone has many factors influencing their characteristics 
such as age, weight, race, diet, genetics and other physiological conditions. Primary 
osteoblasts derived from normal and ovariectomized rats offer advantages such as, more 
accurate depiction of the in vivo situation as opposed to commercial cell lines, ability to 
control age, weight, diet and physiological conditions of normal and osteopenic rats and 
richer source of same seed cells for better comparisons. 
Ovariectomized rat models are the most often used animal models to study 
postmenopausal osteoporosis with estrogen deficiency, because of their numerous 
advantages, such as: low cost, easy and safe to handle, rapid generation time, little 
maintenance requirements, reliable reproducibility of disease and lesser ethical issues 
(Yoon et al. 2012, Lelovas et al. 2008). It is well known that bilateral ovariectomy of rats 
causes a deficiency in estrogen that causes osteopenia of bones, which resembles the 
pathogenesis of postmenopausal osteoporosis (Chow 2008, Yang et al. 2011, Lelovas et 
al. 2008). A recent study on 23 month old SD rats showed that ovariectomy causes a 
decrease in serum estrogen levels from 110 pg/ml to 67 pg/ml in 4 weeks (Yu et al. 
2012). Another study showed that ovariectomy on 11 weeks old SD rat caused a 
significant reduction in estrogen levels from 19.94 pg/ml to 1.64 pg/ml in 8 weeks (Yoon 
et al. 2012). Considering the similarity in age of our rat model, the latter values of bone 
estradiol concentrations of normal and ovariectomized rats would be more comparable to 
this study. From the previous chapter, it was observed that rapid micro-architectural 
changes in the ovariectomized SD rats occurred until 8 weeks post-ovariectomy. 
Significant differences in BMD and trabecular micro-architectural indices and intrinsic 
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cortical bone tissue properties were observed as early as 4 weeks post-ovariectomy. It 
was therefore assumed that to better understand the pathogenesis of the disease, the best 
time to investigate the changes in primary bone cell properties would be the period of 
rapid bone architectural changes, i.e., 4 weeks post-ovariectomy. Thus, this study reflects 
the mechanical, structural and functional changes occurring at the cellular level during 
the early pathogenesis of postmenopausal osteoporosis. 
 The nature of isolated primary bone cell culture was investigated first, to validate 
the comparison between different group cells. All the isolated primary bone cell culture 
from the 8 rats showed positive markers for osteoblastic cells such as, alkaline 
phosphatase activity, mineralization capability and collagen type-I expression. ELF-97 
staining for alkaline phosphatase activity showed that more than 80% of the cells in 
culture expressed alkaline phosphatase. It is possible that the obtained culture is a 
heterogeneous culture with majority of cells exhibiting osteoblastic nature. Following 14 
days post-confluency, the cells synthesizes extracellular matrix (ECM) comprising of 
collagen and calcium hydroxyapatite crystals, confirming that the isolated cells are 
osteoblasts and are capable of differentiation. Cells isolated from femur and tibia, both 
right and left, from the same rat did not exhibit differences amongst them in terms of 
alkaline phosphatase activity, proliferation and other properties. Thus, cells isolated from 
one rat, regardless of the physiological site of origin, were considered similar in 
morphology and functions. 
 In this study, the primary bone cells isolated from ovariectomized rats were found 
to express higher alkaline phosphatase activity as compared to the normal rats. This 
increase in the activity was not influenced by cell number, as the tests were conducted on 
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synchronized confluent cells with contact inhibition (Muthukumaran et al. 2012, Davis et 
al. 2001). The inherent increase in alkaline phosphatase activity of OVX group primary 
cells indicates that these cells have enhanced differentiation capability in vitro (Gray et 
al. 1987). The increased alkaline phosphatase activity of OVX group is in agreement with 
a recent study (Yu et al. 2012). On the other hand, the proliferation rate of the primary 
cells isolated from different groups did not show significant difference in our study, 
whereas Yu et al. (2012) showed that OVX group primary cells had enhanced 
proliferation rate as compared to normal rats. This discrepancy could due to the 
difference in the age of the rats used. We used relatively younger rats (3 months old, as 
opposed to 23 months old rat used by Yu et al.). As the skeleton of the 3 months old rat 
would be actively growing, the proliferation rate of the isolated cells would be higher 
than that of aged rats. Yu et al. (2012) also showed that the proliferation rate of primary 
bone cells from normal rats decreased with the age of the rats. Thus it is possible that the 
increased proliferation rate due to young age could have masked the effect of 
ovariectomy on proliferation rate of the cells in our study. There were few prior studies 
on the comparison of primary osteoblasts cells isolated from normal and osteoporotic 
animals and humans (Yu et al. 2012, Torricelli et al. 2003, Fini et al. 2001, Torricelli et 
al. 2000, Neidlinger-Wilke et al. 1995). Human osteoblastic culture isolated from normal 
and osteopenic humans were observed to show significant differences in terms of 
proliferation, osteocalcin, type I collagen and interleukin-6 expressions, with no 
significant changes in alkaline phosphatase activity (Torricelli et al. 2002). Primary 
osteoblasts isolated from osteopenic sheep did not show significant changes from those 
isolated from normal sheep (Torricelli et al. 2000). Similarly, Fini et al. (2001) reported 
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that significant changes were not observed between primary bone cells isolated normal 
and ovariectomized rats (13 months old and 3 months post-ovariectomy). These 
discrepancies could be due to age discrepancy of human samples and stage of osteopenia 
of the animals at the time of cell isolation. In this study, we have chosen to isolate cells 
from ovariectomized rats during the period of rapid micro-architectural changes. Thus, 
the cells were found to show difference in their basal conditions as opposed to the earlier 
studies on sheep and rats, which isolated bone cells at a later time point, when 
stabilization of bone osteopenia is likely to occur (Egermann et al. 2005).  
 The influence of estradiol was more pronounced on the OVX group primary cells 
than those from SHAM group. Estradiol was observed to increase the alkaline 
phosphatase activity and decrease the proliferation rate of the OVX group cells. This 
observation is in agreement with our previous study which demonstrated that estradiol 
significantly increased the inherent alkaline phosphatase activity of human fetal 
osteoblasts cells (Muthukumaran et al. 2012). However, there was no significant 
influence of estradiol on SHAM group cells proliferation and alkaline phosphatase 
activity. Different studies showed contradicting results that estrogen stimulates, inhibits 
or has no effect on proliferation, alkaline phosphatase activity and osteocalcin expression 
of osteoblasts (Turner et al. 2008, Miki et al. 2009, Gray et al. 1987, Robinson et al. 
2000, Ernst et al. 1989). From this study we can assume that this discrepancy in literature 
data could be due to the sources and nature of the cells chosen for analysis. Overall, 
estradiol was observed to enhance the differentiation and decrease the proliferation of 
only those cells isolated from osteopenic rats. 
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 Bone is known to respond to mechanical stresses by alteration in bone remodeling 
(Morgan et al. 2008, Wolff 1986, Chamay and Tschantz 1972). Being the bone lining 
cells, osteoblasts are often exposed to different kinds of mechanical stresses in vivo, such 
as the fluid shear stress, hydrostatic pressure and stretching stress. Osteoblasts’ response 
to these kinds of mechanical forces could be pivotal to their physiological functions. 
MC3T3-E1, hFOB and primary osteoblastic cells are known to respond to fluid shear 
stress through increased whole cell stiffness and fluid shear induced aggregation of 
cytoskeleton (Jackson et al. 2008, Liu et al. 2010, Jaasma et al. 2007). These studies 
indicate that during the process of mechanotransduction, osteoblasts cells get 
mechanically adapted by rearrangement of cytoskeleton and altered cell stiffness. 
Cellular mechanical adaptation through cytoskeletal rearrangement of osteoblasts can 
play an important role in regulating bone remodeling and hence the bone form and 
function. In this study, a difference in the stiffness of primary bone cells was observed 
between SHAM and OVX groups. This increase in stiffness corresponds with the 
increased actin fibrous network, which was observed by microscopy as well as confirmed 
by quantifying the fluorescence due to phalloidin-TRITC stained cells. The altered 
cytoskeleton and stiffness of OVX group cells could be caused due to the enhanced 
differentiation of OVX group cells (as observed from increased alkaline phosphatase 
activity of the cells). Given the role of cytoskeleton and stiffness of osteoblasts in its 
mechanotransduction, OVX group cells with different stiffness and cytoskeletal 
composition, can respond to mechanical stress in different way or different rate. Thus 
mechanosensory function of OVX and SHAM group cells is speculated to be 
significantly different. In agreement to this, there was a prior study on human osteoblasts 
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from normal and osteoporotic patients, which showed differences in their response to 
cyclic strain in terms of proliferation and TGF-β release (Neidlinger-Wilke et al. 1995). It 
is worthwhile to notice that the measured stiffness of the cells from this study could also 
be influenced by the elasticity of the nucleus of cell, as the indentation was carried out 
using a spherical bead on the center of the cell. Accordingly, a previous study showed 
that nuclei of OVX osteoblasts had fewer nucleoli in their nucleus as compared to SHAM 
group osteoblasts (Yu et al. 2012). Other morphological differences observed in their 
study include fewer folds, lysosomes, peroxisome and rough endoplasmic reticulum and 
more heterochromantin and mitochondria in OVX group cells as compared to SHAM. 
Overall, OVX group primary bone cells were found to be significantly different from 
SHAM group cells in terms of their morphological and mechanical characteristics. With 
the treatment of estradiol, it was observed that the OVX group primary cells became 
more elastic with significant decrease in F-actin network. However, in case of SHAM 
group primary cells, estradiol did not have significant influence on the stiffness or actin 
cytoskeleton of the cells.  
 The elastic modulus of osteoblasts measured by AFM is known to be substrate 
dependent (Takai et al. 2005).  The extracellular matrix (ECM) modulates the 
arrangement of F-actin thereby influencing the measured elastic modulus of the cell. 
Collagen and mineralization expression were assessed after 3 days of seeding to analyze 
the changes in the ECM that could contribute to changes in F-actin structures in the 
experimental groups. There was not much collagen or mineralized matrix expression in 
the cells following 3 days of seeding (results not shown). Thus, the changes in elastic 
modulus of the cells were caused primarily by the cytoskeletal modification. However, 
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following 14 days of confluency, significant deposition of mineralized matrix was 
observed in all experimental groups. OVX group primary bone cells showed lower and 
sparse collagen expression as compared to SHAM group. This is also in accordance with 
a previous study on normal and osteoporotic human osteoblasts, which shows that 
osteoporotic osteoblasts expressed significantly lower type-I collagen as compared to 
those isolated from normal patients (Torricelli et al. 2002). With the treatment of 
estradiol, the collagen expression was found to improve in OVX group primary cells, but 
not as much as that of the SHAM group. SHAM group did not show significant changes 
on treatment with estradiol. Mineralization also followed similar trend with SHAM group 
showing uniform and higher mineral deposits as compared to OVX group. Although 
OVX showed thicker deposits of mineralized nodules, they are very sparse. Estradiol had 
an effect of increased mineral deposits in OVX group. Overall, it was observed that OVX 
group primary cells had an impaired bone matrix synthesis as compared to SHAM group. 







The major conclusions from this study are summarized as follows. 
 Primary bone cells isolated from ovariectomized rats were significantly different in 
their characteristics from those isolated from normal rats. OVX group primary cells 
showed enhanced differentiation, increased stiffness with denser F-actin network and 
impaired matrix synthesis as compared to that of SHAM group. 
 Since the properties of osteoblasts differs according to the physiological condition of 
the rat, it is important to choose appropriate sources of osteoblasts cells according to 
the nature of the research question. 
 Increased stiffness of OVX primary bone cells with denser F-actin network would 
probably result altered mechanosensory function of the cells. 
 Primary bone cells of OVX group were found to be more responsive to estradiol than 
SHAM group. Estradiol was found to enhance differentiation, decrease stiffness with 
lesser actin network, decrease proliferation rate and improve matrix synthesis. 
 The changes in stiffness of cells from different groups were not caused by changes in 
































 In the previous chapters, it is mentioned that estrogen has a direct effect on the 
mechanical property of osteoblasts and their cytoskeletal organization. Since cytoskeletal 
structure and organization is important for mechanosensory function of osteoblasts, it is 
speculated that estrogen will have a direct effect on mechanosensitivity of osteoblasts 
cells. To test this hypothesis, we tested the influence of -estradiol on the 
mechanosensitivity of human fetal osteoblasts cell line (hFOB 1.19) in terms of 
intracellular calcium and nitric oxide response to fluid shear stress. 
6.1. Introduction 
Mechanical adaptation of bone architecture had been a well known phenomenon. 
The bone elements are known to place or displace themselves in the direction of 
functional stresses and increase or decrease their mass to reflect the amount of the 
functional forces (Morgan et al. 2008, Wolff 1986). Thus, bone is known to respond to 
intermittent mechanical loads with changes in bone remodeling (Wolff 1986, Chamay 
and Tschantz 1972). The mechanisms of this mechanical load induced bone remodeling 
would require some form of cellular mechanotransduction (Duncan and Turner 1995). 
Mechanotransduction is defined as the conversion of mechanical signals to a biochemical 
response by the cells. The first step of mechanotransduction is mechanocoupling, the 
transduction of mechanical force applied to the bone into a local mechanical signal 
perceived by a sensor cell, followed by biochemical coupling, the transduction the local 
mechanical signal into biochemical signal and gene expression (Duncan and Turner 
1995). The mechanical environment of bone cells is a dynamic milieu of biophysical 
stimuli that includes stress, strain, shear, pressure, fluid flow, streaming potentials and 
acceleration, with the biological response depending on magnitude, frequency and strain 
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rate (Thompson et al. 2012). There are increasingly strong evidence supporting the view 
that fluid shear is one of the principal forces responsible for bone adaptation (Kamioka et 
al. 2006, Basso and Heersche 2002). Thus, the detection of local mechanical signal as an 
indicator of total loading by the sensor cell is usually assumed to occur through sensing 
of fluid shear stress due to the interstitial fluid flow through the porous regions of bone, 
down the pressure gradient created between the areas of tension and compression 
(Bloomfield 2001). At cellular level, there are evidences showing that osteocytes and 
osteoblasts act as mechanosensors of bone and respond to mechanical forces through 
functional changes and altered bone remodeling (Westbroek et al. 2000, Vezeridis et al. 
2006, Ban et al. 2011, McGarry et al. 2008).  
 The ability of osteoblasts to detect mechanical signals and respond to them with 
appropriate biochemical response was found to be dependent on the cytoskeletal 
organization (Myers et al. 2007, Li et al. 2007, McGarry et al. 2005). Disruption of 
cytoskeletal structures of osteoblastic cells were found to inhibit the c-Fos mRNA and 
protein expression in response to cyclic compression loading, which are important for 
bone formation and mineral deposition (Li et al. 2007). Fluid flow induced prostaglandin 
E2 (PGE2) was observed to enhance in cytoskeleton disrupted osteoblastic cells and 
decrease in cytoskeleton disrupted osteocytic cells (McGarry et al. 2005). These studies 
indicate the importance of cytoskeletal structures for mechanosensory function of bone 
cells. Our previous study indicated that estrogen has a direct effect on mechanical 
property of osteoblasts that occurs through estrogen induced cytoskeletal changes in 
osteoblasts (Muthukumaran et al. 2012).  It is therefore hypothesized that estrogen will 
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have a direct effect on cell mechanosensing function, mechanotransduction and further 
bone remodeling events.  
 There are few studies showing that osteoblasts cells are more responsive to fluid 
shear stress than mechanical stretching (Owan et al. 1997, Smalt et al. 1997). One of the 
earliest events in bone cell mechanotransduction is the intracellular calcium signaling, 
which is an important mechanism in many cellular functions such as differentiation, 
proliferation and gene transcription (Berridge et al. 1998). The measurement of fluid 
shear stress induced transient increases in intracellular calcium levels is considered as a 
useful indicator for studying short-term mechanosensory response in bone cells. The final 
products of complex series of intracellular loading following mechanical stimulation of 
osteoblasts were likely to be generation of nitric oxide (NO) and prostaglandins 
(Bloomfield 2001). Mechanical load-induced release of NO  appears to be another 
important mediation of mechanotransduction in bone cells (Young and Pavalko 2011, 
McGarry et al. 2008). NO is a short-lived diffusible chemical messenger and is known to 
play important role in bone metabolism (Evans and Ralston 1996), possibly through their 
regulation of osteoblasts differentiation and proliferation (Lin et al. 2008). Intracellular 
NO synthesis of mechanosensitive bone cells are known to be crucial for bone 
mechanical adaptation (McGarry et al. 2008). The overall aim of this study was therefore 
to study the direct effect of estrogen on mechanosensitivity of human fetal osteoblasts 
cell line by analyzing the intracellular calcium release and nitric oxide synthesis in 




6.2. Materials and Methods 
Cell culture 
 The human fetal osteoblasts cell line (hFOB 1.19, ATCC CRL-11372) was 
cultured in 1:1 mixture of Ham’s F12 and Dulbecco’s Modified Eagle’s Medium without 
phenol red (Invitrogen), supplemented with 0.3 mg/ml G418 (Sigma Aldrich) and 10%  
fetal bovine serum (FBS, HyClone sera, Thermoscientific). The cells were maintained in 
a 5% carbon-dioxide incubator (Sanyo) at 34 oC. For experimental group cells, the cells 
were grown in the same culture medium supplemented with 10 nM β-estradiol (Sigma 
Aldrich) for at least 3 days. After the cells become 90% confluent, the cells were 
trypsinated and seeded into the flow chambers for further experiments. 
Flow channel setup 
 The schematic flow channel setup used to subject the cells to fluid shear stress is 
shown in Figure 6.1. We used a polydimethylsiloxane (PDMS) generated fluid channels 
in this study. The flow chamber consists of a PDMS channel covalently bonded to 22 mm 
x 60 mm VFM coverslip (CellPath) by plasma treatment using a plasma etcher (MARCH 
instruments incorporated). The PDMS mold consists of the linear channel of length (L) 
15 mm, width (W) 0.5 mm and height (H) 0.15 mm. The fluid flow was facilitated in and 
out of the PDMS channel using Tygon microbore tubes (Cole-Parmer). A 10 ml plastic 
syringe (Terumo) was filled with appropriate fresh culture medium and was connected to 
the inlet microbore tubing using 18G precision tips (Nordson EFD). The medium from 
the syringe was pumped through the inlet tube using the Fusion 200 syringe pump 
(Chemyx Inc.). In order to obtain appropriate fluid shear stress (τ) inside the channel, the 





WHQ                                  (6.1) 
where, η is the viscosity of the medium. The viscosity of the medium was measured using 
a viscometer (Brookfield viscometer DV-II + Pro). The viscosity of both the culture 
medium and the medium supplemented with 10 nM estradiol was measured to be 1.0 cP. 
A labview program was written to achieve step-up and step-down flow patterns and is 
used to control the syringe pump using RS232 cable. 
 
 
Figure 6.1. Schematic diagram of the flow channel setup to study the mechanosensitivity 
of human fetal osteoblasts cell line. 
 
 A low fluid shear stress of 0.25 Pa and 0.5 Pa were achieved at flow rates of 
28.125 µl/min and 56.25 µl/min, respectively. A step-up flow from 0.25 Pa to 0.5 Pa, 
with step value of 0.05 Pa every 5 minutes, was achieved using the labview program. The 
reverse step down function was achieved using the same program. 
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Intracellular calcium imaging 
 The intracellular calcium levels were monitored during fluid shear stress by 
staining the cells with cell permeant calcium sensitive Fluo-3AM dye (Invitrogen). 
Approximately, 1x104 hFOB cells in 100 µl medium were seeded onto the fibronectin 
coated PDMS flow channels. The cells were grown at 34 oC for 1 day. The cells were 
stained according to the protocol (Scheenen et al. 1998). Briefly, the cells were washed 
with physiological saline, and then incubated with Fluo-3AM loading solution for 45 
minutes. The loading solution consisted of 7 µM Fluo-3AM, 0.2% (w/v) of pluoronic F-
127 (Invitrogen), 0.2 mM sulfinpyrazone (Sigma Aldrich), 30 µl of FBS in the saline 
vehicle. After bringing the cells to the flow channel set up, the cells were kept still for at 
least 30 minutes to allow the intracellular calcium level to the baseline value. The flow 
was started and the changes in the intracellular calcium levels were captured in time-
lapse, using Olympus IX-81 fluorescent microscope with digitized stage and cell chamber 
for temperature maintenance at 37 oC. The images were captured at 1 frame per 3 
seconds. The changes in fluorescence intensity following fluid flow were analyzed using 
ImageJ software (National Institutes of Health). Briefly, the time-lapse sequence is 
opened as a stack in ImageJ. The outline of the cell is drawn on one slice, and the mean 
gray value for the whole stack is measured. The gray value for the background is 
measured. The differences in the gray value would be the measure of fluorescence 
intensity and therefore, the intracellular calcium concentration levels. The percentage 
increase in the gray value was calculated based on the baseline value. The maximum 




Nitric oxide synthesis 
 For analysis of NO synthesis, the cells were seeded onto the fibronectin coated 
PDMS channels, in the similar manner as prepared for intracellular calcium analysis. The 
flow channel was placed on a thermo plate (Tokai Hit) to maintain the temperature at 37 
oC. The channel is then wired according to the flow channel set up. After buffering the 
cells for at least 30 minutes, the flow was initiated. The outlet discard medium was 
collected every 15 minutes for 150 minutes. The NO concentration in the discard medium 
was measure indirectly by nitrite and nitrate determination, as the NO released into the 
medium tends to quickly metabolize to more stable compounds of nitrite and nitrate. 100 
µl of the discard medium was added to equal volume of Griess reagent (Sigma Aldrich) 
in a 96-well tissue culture plate (Greiner Bio one). After 10 minutes of incubation the 
absorbance was measured at 550 nm using a microplate reader (FLUOstar OPTIMA, 
BMG labtech). The nitrite concentration in the medium was determined from a sodium 
nitrite standard curve using 0-100 µM NaNO2.  
Statistical analysis 
 Statistical analyses were carried out using SPSS v16 software and all the 
results are reported as meanSD (standard deviation). One-way analysis of variance 
(ANOVA) was performed for all comparisons. Bonferroni post-hoc corrections were 





 Figure 6.2 shows the image of the control and estradiol group hFOB 1.19 cells 
before and after the initiation of fluid shear stress. The images were converted with 16-
color look-up table using ImageJ to better represent the changes in fluorescence intensity. 
The after flow image shows the image of the cell at the time point of peak fluorescence 
intensity, i.e, 6 seconds and 3 seconds after the initiation of fluid shear stress for control 
and estradiol groups, respectively. 
 
Figure 6.2. 16-color look-up table corrected 8-bit images of control and estradiol group 





Figure 6.3 represents the time to peak intensity and maximum peak intensity for 
both control and estradiol groups. The time to peak intensity might not be very accurate 
as the image capture speed was set at 1 frame per 3 second. The time to peak intensity 
was found to be mostly 3 seconds for estradiol treated cells and mostly 6 for control 
group cells. For n=6 cells, the average time to peak intensity at 0.5 Pa fluid shear stress 
was found to be significantly different (p=0.035). The peak intensity attained, as 
percentage of baseline value, was found to be significantly higher for estradiol group, as 
compared to the estradiol group cells (p<0.001, n=6). These results show that the peak 
intracellular calcium concentration, in response o fluid shear stress, was higher and 




Figure 6.3. Time to peak intensity and maximum peak intensity of control and estradiol 
treated cells, n=6. Error bar indicates standard deviation. * indicates statistically 






Nitric oxide synthesis 
 The concentration of NO in the collected discard medium (every 15 minutes) was 
determined using Griess reagent. The discard concentrations of nitrite at various time 
points, as determined from the sodium nitrite standard graph of both estradiol and control 
groups, are represented in Figure 6.4. The discard concentration started to show 
significant increase started from 135 minutes after start of flow. Although the estradiol 
group showed higher concentrations of nitrites than the control group at various time 
points, statistically significant increase was observed only at 150 minutes after the start of 
flow (p=0.03, n=3). 
 
Figure 6.4. Average nitrite concentrations at various time points in the discard medium 
from the flow experiments using control and estradiol group cells, n=3. Error bar 
indicates standard deviation. * indicates statistically significant difference as compared to 




 Bone, in a way, may be considered as a very stiff sponge, full of tiny pores and 
filled with a viscous fluid. On compression, this fluid is squeezed through the thin pores 
and during relaxation the fluid flows back again. Thus, on loading, the interstitial fluid of 
bone tissue is squeezed through the thin layer of non-mineralized matrix surrounding the 
cell bodies (Burger and Klein-Nulen 1999). Most of studies on osteoblasts response to 
mechanical stress use parallel plate flow chamber with variable dimensions of higher 
order dimensions than used for this study (500 µm width and 150 µm height). We used a 
simple linear PDMS channel of smaller dimensions as it would be more similar to the 
microporous networks of bone tissue than the parallel plate chambers. Using this 
chamber, we tested response of osteoblasts to low fluid shear stress ranging from 0.25 Pa 
to 0.5 Pa. Lower range of fluid shear stress were chosen in order to understand the 
minimum required fluid shear stress to activate the osteoblasts cells. At 0.25 Pa wall 
shear stress, the osteoblasts response to shear stress was found to be variable. Only 2 out 
of 6 cells tested were found to be responsive (data not shown). At 0.5 Pa all the cells were 
found to be responsive to fluid shear stress. Step-up and step-down flow patterns yielded 
similar response as that of the initial flow rate. Therefore, for comparison of estrogen 
effects on the osteoblasts cells, only flow rate of 0.5 Pa was considered.  
 Gap junctional communication between adjacent cells could interfere with the 
intracellular calcium levels. To exclude this interference, only those cells which are not in 
contact with other cells were considered for the experiments. The increase in intracellular 
calcium levels during the first few minutes after the onset of fluid flow was evaluated to 
assess the effect of estrogen on the early response of osteoblasts to fluid shear stress. 
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Previous studies showed that after the onset of flow there is a transient calcium peak, 
observed within 15 seconds (Kamioka et al. 2006, Chen et al. 2000, Donahue et al. 2001).  
Similarly, in this study, we observed a transient peak of intracellular calcium levels in 
both control and estradiol group osteoblasts cells. The difference in the characteristics of 
calcium response between control and estradiol treated hFOB cells were assessed in 
terms of time to peak intensity and percentage increase in intensity during the peak. We 
observed that estradiol treated cells achieved calcium peaks earlier with higher intensity 
as compared to the control group cells.  
 An in vivo study on rodent models demonstrated that treatment with nitric oxide 
inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) inhibited mechanically 
induced bone formation. Their results suggest that NO play an important role in the 
transduction of mechanical stimulus into biological response in bone. Thus, NO is 
considered as an important signaling molecule for mechanically induced bone remodeling 
and changes in NO levels correspond to degree of bone cell activation (Vatsa et al. 2006). 
In this study, estradiol was shown to have enhancing influence on bone cell activation 
due to fluid shear stress, as NO released by estradiol treated cells was significantly higher 
than that of normal cells. This increase in NO response could possibly be caused by the 
previously demonstrated changes in F-actin organization and stiffness of the estradiol 
treated cells (Muthukumaran et al. 2012). A previous study demonstrated that cellular NO 
response to AFM indentation force was associated with indentations on stiffer membrane 
sites, suggesting cytoskeletal involvement in NO response (McGarry et al. 2008). The 
reduced stiffness of estradiol treated osteoblasts cells along with F-actin cytoskeletal 
modification could possibly contribute to the changes in NO response of the cells.  
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 There were very few studies which focused on the estrogen involvement in bone 
cell mechanotransduction (Joldersma et al. 2001, Ren et al. 2012, Aguirre et al. 2007, 
Bakker et al. 2005). In vivo analysis of estrogen receptors α and β (ERα and ERβ) 
knocked out mice showed poor osteogenic response to bone loading (Lee et al. 2003). 
Earlier study on primary bone cells isolated from elderly non-osteoporotic women 
showed that estrogen enhances the expression of prostaglandin and COX-1 mRNA 
expression, suggesting the influence of estrogen on bone cell mechanosensitivity 
(Joldersma et al. 2001). On the other hand, another later study from the same research 
group showed that the effects of estrogen and mechanical stress on NO and prostaglandin 
expression in bone cells are additive and not synergistic, suggesting that estrogen might 
not promote mechanotransduction in the cells, but just has a modulatory function (Bakker 
et al. 2005). Another study on ERα and ERβ knocked out osteoblastic and osteocytic 
culture demonstrated that estrogen receptors participate in the mechanotransduction of 
bone cells in a ligand-independent manner (Aguirre et al. 2007). Another recent study on 
the influence of estradiol on osteocyte mechanotransduction showed that estradiol 
increased connexin 43-based gap junction intercellular communication through ERα/β 
pathway and therefore enhanced the osteocytes mechanosensitivity (Ren et al. 2012). All 
these studies suggest a role for estrogen in the mechanotransduction of osteoblasts and 
osteocytes cells. 
 We have identified certain limitations of the study. Although interstitial fluid flow 
is a potent regulator of bone mechanical adaptation, fluid shear stress is considered as 
potent regulator of osteocytic metabolism, rather than the osteoblasts. The in vivo 
mechanical environment of osteoblastic cells was not well-defined. Apart from the 
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hydrostatic pressures and fluid shear stresses from interstitial fluid flow, matrix strain 
under loading could be an important mechanical stimulus for the osteoblasts that reside 
on the mineralized tissues (Chen et al. 2010). Mechanical strain is known to significantly 
induce osteogenic differentiation, suppress adipogenic differentiation and increased 
expression of alkaline phosphatase activity (David et al. 2007, Tanno et al. 2003). Thus, 
further investigation of estrogen effects on osteoblasts response to different kinds of 
mechanical stimulus such as, uniaxial and biaxial stretch, hydrostatic compression, high 
frequency-low magnitude vibration etc, would be required for further understanding of 
estrogen’s influence on osteoblasts mechanosensitivity.  
 In summary, we studied the direct effect of estradiol on earlier calcium response 
and the final NO release of osteoblastic cells in response to fluid shear. Both the 
expression of earlier calcium ion signal and later NO production suggested that estrogen 
has a direct effect of mechanosensitivity of osteoblasts cells. We could speculate the 
involvement of cell stiffness and actin cytoskeleton in this pathway, as our previous study 
showed that estrogen has a direct effect on osteoblasts stiffness and F-actin modifications 
(Muthukumaran et al. 2012). Given the importance of cytoskeletal structures to the 
mechanosensory function, estrogen induced cytoskeletal changes could play an important 
role in mechanosensitivity of hFOB cells. Estrogen is therefore postulated to involve in 




 Estrogen treated cells were found to have earlier and increased intracellular calcium 
levels as compared to the control group cells, in response to low fluid shear stress. 
 Estrogen treated cells showed increased nitric oxide expression in response to fluid 
shear stress. 
 Estrogen was found to have direct effect on osteoblasts mechanosensitivity, which 
could have resulted from altered mechanical property and cytoskeletal organization of 























This thesis focused on studying the effects of estrogen on mechanical, structural 
and functional properties of osteoblasts cells in vivo and in vitro to better understand the 
mechanistic perspective of pathogenesis of osteoporosis. The direct effect of estrogen on 
the mechanical properties of commercially available human fetal osteoblasts cell line, in 
vitro, was analyzed using Atomic Force Microscopy. The underlying cytoskeletal 
changes and therefore the mechanosensing changes were also assessed in vitro. The 
effect of in vivo loss of estrogen on bone was assessed using ovariectomized rat models. 
Tissue-level properties were extensively studied in terms of various different aspects of 
bone tissue strength. Cellular level changes were assessed on isolated primary cells in 
terms of their mechanical, structural and functional properties. 
7.1. Conclusions 
 Estrogen was observed to have direct effect on the structure, property and 
function of human fetal osteoblasts cells in vitro. Estrogen was observed to significantly 
reduce the stiffness of the cells, which could arise from changes in F-actin structures. 
Estrogen was also observed to significantly increase inherent alkaline phosphatase 
activity of the cells. The changes in stiffness and cytoskeletal structures were not caused 
by changes in the mineralized matrix formation by the cells. However, after 11 days  
post-confluency, estrogen causes decreased and uniform deposition of mineralized matrix 
as opposed to thicker and sparse nodules present in cells not treated with estrogen. The 
direct effect of estrogen on the mechanosensory function of osteoblasts was also 
established with intracellular calcium response and nitric oxide synthesis in response to 
fluid shear stress. Estrogen was found to enhance the mechanosensory response of 
calcium and nitric oxide. The intracellular calcium peak following the onset of fluid flow 
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was observed to occur earlier and higher in magnitude in cells treated with estradiol. 
Nitric oxide expression following fluid flow was also enhanced in estrogen treated cells. 
These changes in mechanosensory function could be positively associated with changes 
in mechanical properties and cytoskeletal structures of the cells. Thus, estrogen was 
observed to have a direct effect on mechanical property and mechanosensory function of 
the cells, which infers a possibility that pathogenesis of postmenopausal osteoporosis, 
which occurs due to estrogen deficiency, could be associated with defective osteoblasts 
with altered mechanical property and defective mechanosensory functions, along with 
defective differentiation capability and matrix synthesis. 
 Following the preliminary in vitro results suggesting the influence of estrogen on 
mechanical and structural properties of osteoblasts, we further analyzed the effects of in 
vivo loss of estrogen on bone tissue and cell properties. Ovariectomized rat models were 
used for that purpose. Bilateral ovariectomy in rats has long been known to elicit an early 
skeletal response that is similar to those in postmenopausal osteoporosis. Ovariectomy 
induced changes in long bone tissue of rodent models were assessed extensively using 
various parameters. Ovariectomy induced estrogen loss in rodents were found to be 
associated with rapid microarchitectural deterioration, which was evident from the 
significantly reduced BV/TV, Tb.Th and Tb.N and significantly increased SMI, Tb.Po 
and Tb.Sp. Densitometric reduction of bone mass was significantly observed in 
trabecular bone whereas cortical BMD increased or remained unchanged. The mean 
BMD of bone tissue significantly reduced as early as 4 weeks post-ovariectomy. Reduced 
mean BMD was associated with reduced Fmax of tibia bone, indicating that BMD could 
still be considered potential bone strength predictor. Intrinsic bone tissue properties such 
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as nano-level elastic modulus and hardness of cortical bone were observed to be 
adversely affected, whereas trabecular bone intrinsic properties did not show significant 
changes. Thus, despite an increasing/unchanging cortical BMD, the intrinsic bone quality 
of cortical tissue was adversely affected by estrogen deficiency in rats. Ovariectomy was 
also associated with reduced viscosity of cortical bone, and hence poor viscoelastic 
properties. The reduction in viscosity was associated with poorly formed bone matrix 
with micropores and nanovoids. Viscosity can thus be postulated as an indicator or 
micro-fracture propagation in bone, but it requires large scale study. Apart from 
adversely affected intrinsic tissue property and viscoelasticity of cortical bone, the 
cortical bone geometry was also greatly affected due to increased periosteal formation 
and endocortical resorption, resulting in reduced cortical thickness and area. Taken 
together, the cortical bone strength is greatly affected due to estrogen deficiency in terms 
of its intrinsic material property, viscoelasticity and geometry. Overall, the trabecular and 
cortical bone tissue were found to be affected in different manner following ovariectomy 
induced estrogen deficiency with an overall reduction in bone strength. 
 To assess the cellular effects of estrogen loss in vivo, primary bone cells were 
isolated from ovariectomized and normal rats. All the isolated primary bone cells showed 
positive markers for osteoblastic cells such as alkaline phosphatase activity, collagen type 
I and mineral matrix synthesis. The bone cells isolated from ovariectomized and normal 
rats showed significantly different characteristics in terms of their mechanical property, 
structure and function. Primary bone cells from osteopenic bone showed enhanced 
differentiation, increased stiffness with denser F-actin network. The synthesis of mineral 
matrix and collage type-I was found to be adversely influenced. However, the changes in 
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stiffness and altered cytoskeletal structures were not caused due to changes in the 
extracellular matrix. Primary bone cells from ovariectomized rats were observed to be 
more responsive to in vitro treatment of estrogen than those from normal rats. Estrogen 
was found to decrease the stiffness of the cells, with less dense F-actin structures. 
Further, estrogen also increased differentiation and reduced proliferation of the primary 
bone cells from osteopenic bone tissue. There was an observed improvement in matrix 
synthesis of osteopenic osteoblasts following estrogen treatment. Overall, the primary 
bone cells from ovariectomized rats were found to have impaired properties, which could 
be positively influenced by estrogen levels. The significantly altered stiffness and 
cytoskeletal structures of osteopenic bone cells could result in poor mechanosensory 
functions. Overall, this thesis work suggests that the pathogenesis of postmenopausal 
osteoporosis could be associated with reduced bone mass and poor intrinsic bone quality 
at a tissue-level and impaired mechanical property and structure at cellular level, which 
could have influences on mechanosensory functions of the cells. Apart from having 
functional changes associated with the mechanical property changes of the bone cells, the 
stiffness of the bone cells, by themselves, could also possibly influence the bone tissue 




Original Contributions of the thesis 
 There are three important original contributions in this thesis. They are 
summarized as follows: 
 The direct effects of estradiol on mechanical properties of osteoblasts in vitro were 
documented and quantified for the first time. The cytoskeletal contribution to the 
changes in elastic modulus was substantiated, indicating the possible role of estradiol 
on mechanotransduction pathways of osteoblasts’ response to stress. The 
mechanosensory functions of intracellular calcium response and terminal nitric oxide 
release were also shown to be directly influenced by estradiol.  
 Ovariectomy induced in vivo loss of estrogen was shown to influence the properties 
of isolated primary bone cells. Primary bone cells from ovariectomized rats showed 
to have increased stiffness with denser f-actin network, enhanced differentiation and 
impaired matrix synthesis. Primary bone cells isolated from ovariectomized rats 
were shown to be more responsive to estrogen than those from normal rats. 
 Nano-level intrinsic tissue properties of cortical and trabecular bone, following 
ovariectomy induced estrogen loss, was studied. Where BMD and micro-
architectural deterioration were more pronounced on trabecular bone, intrinsic tissue 
modulus, hardness and viscosity were adversely affected on cortical bone. Viscosity 
changes of cortical bone was shown to associate with poor bone matrix, indicating 





7.2. Future work 
 The work in this thesis gives a basic understanding on the intrinsic tissue changes 
and mechanistic changes of bone cells during the pathogenesis of postmenopausal 
osteoporosis. These studies would find applications in future to design new therapeutic 
products for the treatment of postmenopausal osteoporosis as well as to test the efficacy 
of presently available drugs. Future work can include the following: 
 Extensive studies on the effect of estrogen on mechanosensory function of osteoblasts 
are required as a future work. The effects of estrogen on various mechanosensory 
events of osteoblasts should be extensively studied for various flow rates and flow 
patterns. The genetic pathways involved in this mechanotransduction events 
involving estrogen should be documented. 
 Various therapeutic products such as SERMs, bisphosphonates and human 
parathyroid hormone (hPTH) could be tested in vivo and in vitro to test the efficacy of 
drugs in terms of changes in mechanical properties of osteoblasts. 
 The mechanical property and mechanosensitivity of osteoblasts could be documented 
in a parallel study to better quantify the effects of changes in mechanical properties of 
the cells on the mechanosensing ability. Cytoskeletal disruption could form as a part 
to better document the influence of cytoskeletal disruption on mechanical property 
and mechanosensitivity of the cells. 
 This study is limited to bone forming osteoblasts. However, the major cellular 
component of bone tissue and major mechanosensors are the osteocytic cells. Future 
work can focus on the mechanical property and mechanosensitivity changes of 
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